Dr. Mehra serves as The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine and as Executive Director of the Center for Advanced Heart Disease, Brigham and Women’s Hospital. He is a Professor of Medicine at Harvard Medical School and Editor-in-Chief, The Journal of Heart and Lung Transplantation. Dr. Mehra is a Past-President (2008) of the International Society of Heart and Lung Transplantation (ISHLT) and past president (2016) of the Heart Failure Society of America (HFSA). He has authored and published over 500 scholarly papers with a specific focus on Advanced Heart Failure. Dr. Mehra has also completed a Master of Science in Health Economics and Management at the London School of Economics in 2018, a degree earned through his designation as a “Braunwald Scholar”. Dr. Mehra is recognized as one of the leading cardiologists in advanced heart failure and cardiac transplantation worldwide and his research focuses on mechanical circulatory support devices, the practice of cardiac transplantation, and innovative care processes for Advanced Heart Failure with a focus on value as we transition into a new Healthcare Era.
The Dilemma of Exertional Dyspnea and Diagnosis of Heart Failure: Convergent and Discriminant Validity. JACC Cardiovasc Imaging. 2019 05; 12(5):781-783.
The Dilemma of Exertional Dyspnea and Diagnosis of Heart Failure: Convergent and Discriminant Validity.
Levesque AA, Rimsans JM, Sylvester KW, Lyons EN, Frankel KA, Coakley LL, Hickey M, Montoya KA, Mehra MR, Givertz MM, Stewart GC, Connors JM
Development of an Outpatient Guideline for Optimal Anticoagulation Bridging in Patients With Durable Mechanical Circulatory Support. Crit Pathw Cardiol. 2018 03; 17(1):32-37.
Development of an Outpatient Guideline for Optimal Anticoagulation Bridging in Patients With Durable Mechanical Circulatory Support.
Sangha SS, Uber PA, Park MH, Scott RL, Mehra MR
Congestive heart failure (Greenwich, Conn.)
Difficult cases in heart failure: the challenge of neurocognitive dysfunction in severe heart failure. Congest Heart Fail. 2002 Jul-Aug; 8(4):232-4.
Difficult cases in heart failure: the challenge of neurocognitive dysfunction in severe heart failure.
Journal of the American College of Cardiology
C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link? J Am Coll Cardiol. 2003 Aug 06; 42(3):483-5.
C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link?
Mehra MR, Goldstein DJ, Uriel N, Cleveland JC, Yuzefpolskaya M, Salerno C, Walsh MN, Milano CA, Patel CB, Ewald GA, Itoh A, Dean D, Krishnamoorthy A, Cotts WG, Tatooles AJ, Jorde UP, Bruckner BA, Estep JD, Jeevanandam V, Sayer G, Horstmanshof D, Long JW, Gulati S, Skipper ER, O'Connell JB, Heatley G, Sood P, Naka Y
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
Mitral regurgitation in chronic heart failure: more questions than answers? Curr Cardiol Rep. 2004 Mar; 6(2):96-9.
Mitral regurgitation in chronic heart failure: more questions than answers?
An update on clinical outcomes in heart and lung transplantation. Transplantation. 2004 May 15; 77(9 Suppl):S68-74.
An update on clinical outcomes in heart and lung transplantation.
Mehra MR, Uber PA, Potluri S, Ventura HO, Scott RL, Park MH
Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol. 2004 Aug 15; 94(4):454-8.
Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
Schwartz DJ, Kop WJ, Park MH, Vesely MR, Li S, Mehra MR, Gottdiener JS
Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertension. Am J Cardiol. 2008 Nov 01; 102(9):1273-7.
Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertension.
Highlights of the 2008 Scientific Sessions of the Heart Failure Society of America. Toronto, Ontario, Canada, September 20-23, 2008. J Am Coll Cardiol. 2009 Feb 10; 53(6):514-22.
Highlights of the 2008 Scientific Sessions of the Heart Failure Society of America. Toronto, Ontario, Canada, September 20-23, 2008.
Kobashigawa J, Mehra M, West L, Kerman R, George J, Rose M, Zeevi A, Reinsmoen N, Patel J, Reed EF
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant. 2009 Mar; 28(3):213-25.
Report from a consensus conference on the sensitized patient awaiting heart transplantation.
Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009 Apr; 157(4):754-62.e2.
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
Berg DD, Vaduganathan M, Upadhyay GA, Singh JP, Mehra MR, Stewart GC
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems. J Am Coll Cardiol. 2018 04 03; 71(13):1483-1493.
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems.
Ali A, Mehra MR, Stapleton DD, Kemmerly SA, Ramireddy K, Smart FW, Augustine S, Ventura HO
Vibrio vulnificus sepsis in solid organ transplantation: a medical nemesis. J Heart Lung Transplant. 1995 May-Jun; 14(3):598-600.
Vibrio vulnificus sepsis in solid organ transplantation: a medical nemesis.
British journal of clinical pharmacology
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group. Br J Clin Pharmacol. 1994 Sep; 38(3):257-63.
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group.
Peters TK, Jewitt-Harris J, Mehra M, Muratti EN
Safety and tolerability of fluvastatin with concomitant use of antihypertensive agents. An analysis of a clinical trial database. Am J Hypertens. 1993 Nov; 6(11 Pt 2):346S-352S.
Safety and tolerability of fluvastatin with concomitant use of antihypertensive agents. An analysis of a clinical trial database.
Stapleton DD, Mehra MR, Dumas D, Smart FW, Milani RV, Lavie CJ, Ventura HO
Lipid-lowering therapy and long-term survival in heart transplantation. Am J Cardiol. 1997 Sep 15; 80(6):802-5.
Lipid-lowering therapy and long-term survival in heart transplantation.
Harjai KJ, Boulos LM, Smart FW, Turgut T, Krousel-Wood MA, Stapleton DD, Mehra MR, Murgo JP, Ventura HO
Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure. Am J Cardiol. 1998 Jul 01; 82(1):82-5.
Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure.
Eisen HJ, Hobbs RE, Davis SF, Carrier M, Mancini DM, Smith A, Valantine H, Ventura H, Mehra M, Vachiery JL, Rayburn BK, Canver CC, Laufer G, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Masters R, Michaud JL, Paradis I, Renlund DG, Vanhaecke J, Mellein B, Mueller EA
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. Transplantation. 2001 Jan 15; 71(1):70-8.
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.
Uber PA, Mehra MR, Scott RL, Prasad AK, Park MH
Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1581-2.
Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation.
Targeted in vitro and in vivo gene transfer into T lymphocytes: potential of direct inhibition of allo-immune activation. BMC Immunol. 2006 Nov 10; 7:26.
Targeted in vitro and in vivo gene transfer into T lymphocytes: potential of direct inhibition of allo-immune activation.
Highlights of the 2007 Scientific Meeting of the Heart Failure Society of America: Washington, DC, September 16-19, 2007. J Am Coll Cardiol. 2008 Jan 22; 51(3):320-7.
Highlights of the 2007 Scientific Meeting of the Heart Failure Society of America: Washington, DC, September 16-19, 2007.
The dilemma of late-stage heart failure. Rationale for chronic parenteral inotropic support. Cardiol Clin. 2001 Nov; 19(4):627-36.
The dilemma of late-stage heart failure. Rationale for chronic parenteral inotropic support.
Neonatal congenital heart disease and "complex" heart failure. Congest Heart Fail. 2002 May-Jun; 8(3):188-90.
Neonatal congenital heart disease and "complex" heart failure.
Difficult cases in heart failure: chemotherapy-related cardiomyopathy--all that glitters is not gold. Congest Heart Fail. 2003 Jan-Feb; 9(1):47-9.
Difficult cases in heart failure: chemotherapy-related cardiomyopathy--all that glitters is not gold.
Majeed F, Kop WJ, Poston RS, Kallam S, Mehra MR
Nature clinical practice. Cardiovascular medicine
Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices. Nat Clin Pract Cardiovasc Med. 2009 Feb; 6(2):147-57.
Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.
Walsh MN, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Fonarow GC
Electronic health records and quality of care for heart failure. Am Heart J. 2010 Apr; 159(4):635-642.e1.
Electronic health records and quality of care for heart failure.
Potapov EV, Netuka I, Kaufmann F, Falk V, Mehra MR
Strategy for surgical correction and mitigation of outflow graft twist with a centrifugal-flow left ventricular assist system. J Heart Lung Transplant. 2018 05; 37(5):670-673.
Strategy for surgical correction and mitigation of outflow graft twist with a centrifugal-flow left ventricular assist system.
Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, Kociol RD, Lewis EF, Mehra MR, Pagani FD, Raval AN, Ward C
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018 05 15; 137(20):e578-e622.
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
O'Donnell AE, Schaefer KG, Stevenson LW, DeVoe K, Walsh K, Mehra MR, Desai AS
Social Worker-Aided Palliative Care Intervention in High-risk Patients With Heart Failure (SWAP-HF): A Pilot Randomized Clinical Trial. JAMA Cardiol. 2018 06 01; 3(6):516-519.
Social Worker-Aided Palliative Care Intervention in High-risk Patients With Heart Failure (SWAP-HF): A Pilot Randomized Clinical Trial.
Netuka I, Ivák P, Tucanová Z, Gregor S, Szárszoi O, Sood P, Crandall D, Rimsans J, Connors JM, Mehra MR
Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study. J Heart Lung Transplant. 2018 05; 37(5):579-586.
Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.
Walsh MN, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Fonarow GC
Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. J Card Fail. 2010 Dec; 16(12):940-9.
Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF.
Potluri S, Ventura HO, Mulumudi M, Mehra MR
Cardiac troponin levels in heart failure. Cardiol Rev. 2004 Jan-Feb; 12(1):21-5.
Cardiac troponin levels in heart failure.
Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH
The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 2004 Mar 03; 43(5):806-10.
The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study.
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010 Jan 15; 105(2):255-60.
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF).
Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010 Aug 10; 122(6):585-96.
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database. Am J Med. 1994 Jun 06; 96(6A):79S-83S.
Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database.
Mehra MR, Jarcho JA, Cherikh W, Vaduganathan M, Lehman RR, Smits J, Stehlik J
The Drug-Intoxication Epidemic and Solid-Organ Transplantation. N Engl J Med. 2018 05 17; 378(20):1943-1945.
The Drug-Intoxication Epidemic and Solid-Organ Transplantation.
Mehra MR, Reyes P, Benitez RM, Zimrin D, Gammie JS
Surgery for severe mitral regurgitation and left ventricular failure: what do we really know? J Card Fail. 2008 Mar; 14(2):145-50.
Surgery for severe mitral regurgitation and left ventricular failure: what do we really know?
Rimsans J, Levesque A, Lyons E, Sylvester K, Givertz MM, Mehra MR, Stewart GC, Connors JM
Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices. J Thromb Thrombolysis. 2018 Aug; 46(2):180-185.
Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
Buckley LF, Cooper IM, Navarro-Velez K, Shea EL, Joly JM, Mehra MR, Stevenson LW, Desai AS
Heart & lung : the journal of critical care
Burden of nursing activities during hemodynamic monitoring of heart failure patients. Heart Lung. 2018 Jul - Aug; 47(4):304-307.
Burden of nursing activities during hemodynamic monitoring of heart failure patients.
Risk assessment in critically ill patients awaiting transplantation: a step forward. Rev Esp Cardiol. 2011 Mar; 64(3):175-6.
Risk assessment in critically ill patients awaiting transplantation: a step forward.
Richardson WS, Surowiec WJ, Carter KM, Howell TP, Mehra MR, Bowen JC
Gallstone disease in heart transplant recipients. Ann Surg. 2003 Feb; 237(2):273-6.
Gallstone disease in heart transplant recipients.
Diverse populations, new techniques: non-surgical advances in heart failure 2003. Congest Heart Fail. 2003 Jul-Aug; 9(4):189-90.
Diverse populations, new techniques: non-surgical advances in heart failure 2003.
Mehra MR, Salerno C, Cleveland JC, Pinney S, Yuzefpolskaya M, Milano CA, Itoh A, Goldstein DJ, Uriel N, Gulati S, Pagani FD, John R, Adamson R, Bogaev R, Thohan V, Chuang J, Sood P, Goates S, Silvestry SC
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened. J Am Coll Cardiol. 2005 Feb 01; 45(3):388-90.
Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened.
Mehra MR, Uber PA, Park MH, Ventura HO, Scott RL
Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. Transplant Proc. 2004 Dec; 36(10):3152-5.
Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits.
Emergence of Laplace therapeutics: declaring an end to end-stage heart failure. Congest Heart Fail. 2002 Jul-Aug; 8(4):228-31, 234.
Emergence of Laplace therapeutics: declaring an end to end-stage heart failure.
Ventura HO, Mehra MR, Smart FW, Stapleton DD
Cardiac allograft vasculopathy: current concepts. Am Heart J. 1995 Apr; 129(4):791-9.
Cardiac allograft vasculopathy: current concepts.
Mehra MR, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC
Pacing and clinical electrophysiology : PACE
Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. Pacing Clin Electrophysiol. 2012 Feb; 35(2):135-45.
Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients.
Wilcox JE, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Heywood JT, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Gheorghiade M
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012 Jan; 163(1):49-56.e2.
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF.
Strickberger SA, Conti J, Daoud EG, Havranek E, Mehra MR, Piña IL, Young J
Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation. 2005 Apr 26; 111(16):2146-50.
Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.
Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009 Jun; 157(6):957-70.
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF. Congest Heart Fail. 2009 Jul-Aug; 15(4):157-8.
Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF.
Gene-based bio-signature patterns and cardiac allograft rejection. Heart Fail Clin. 2010 Jan; 6(1):87-92.
Gene-based bio-signature patterns and cardiac allograft rejection.
The emergence of a dynamic intervention paradigm in heart failure. Ochsner J. 1999 Apr; 1(2):63-6.
The emergence of a dynamic intervention paradigm in heart failure.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter. Am J Transplant. 2006 Jun; 6(6):1243-5.
Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter.
Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. Am Heart J. 2007 Jun; 153(6):932-40.
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland JG, Fedele F, Fonarow GC, Maggioni AP, Mebazaa A, Mehra M, Metra M, Nodari S, Pang PS, Ponikowski P, Sabbah HN, Komajda M, Butler J
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013 Mar; 18(2):107-22.
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.
JHLT highlights 2011: cardiothoracic transplantation, pulmonary hypertension, and mechanical circulatory support. J Heart Lung Transplant. 2012 Dec; 31(12):1257-61.
JHLT highlights 2011: cardiothoracic transplantation, pulmonary hypertension, and mechanical circulatory support.
Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, Kon Z, Reyes PA, Zimrin DA
Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J. 2008 Apr; 155(4):661-7.
Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes.
Rogers JS, Zakaria S, Thom KA, Flammer KM, Kanno M, Mehra MR
Immune reconstitution inflammatory syndrome and human immunodeficiency virus-associated myocarditis. Mayo Clin Proc. 2008 Nov; 83(11):1275-9.
Immune reconstitution inflammatory syndrome and human immunodeficiency virus-associated myocarditis.
Mehra MR, Uber PA, Lavie CJ, Milani RV, Park MH, Ventura HO
High-density lipoprotein cholesterol levels and prognosis in advanced heart failure. J Heart Lung Transplant. 2009 Sep; 28(9):876-80.
High-density lipoprotein cholesterol levels and prognosis in advanced heart failure.
Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010 Mar; 16(3):230-8.
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure.
Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF. Circ Heart Fail. 2010 Sep; 3(5):596-605.
Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
Harinstein ME, Flaherty JD, Fonarow GC, Mehra MR, Lang RM, Kim RJ, Cleland JG, Knight BP, Pang PS, Bonow RO, Gheorghiade M
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period. Heart. 2011 Oct; 97(19):1607-18.
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period.
Laboratory investigation; a journal of technical methods and pathology
Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model. Lab Invest. 2012 Feb; 92(2):224-35.
Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model.
Mehra M, Kambili C, Potluri R, Rhines A, Singh V, Thomas A
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India. Int J Tuberc Lung Dis. 2017 08 01; 21(8):902-909.
Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India.
Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease. N Engl J Med. 2018 10 04; 379(14):1332-1342.
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
The Mona Lisa Decrypted: Allure of an Imperfect Reality. Mayo Clin Proc. 2018 09; 93(9):1325-1327.
The Mona Lisa Decrypted: Allure of an Imperfect Reality.
Magnetically Levitated Cardiac Pump at 2 Years. N Engl J Med. 2018 08 30; 379(9):897.
Magnetically Levitated Cardiac Pump at 2 Years.
The gut microbiome and transplantation: An amazon jungle. J Heart Lung Transplant. 2018 09; 37(9):1043-1044.
The gut microbiome and transplantation: An amazon jungle.
Mehra MR, Ventura HO, Stapleton DD, Smart FW
The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. J Heart Lung Transplant. 1995 Nov-Dec; 14(6 Pt 2):S207-11.
The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
Mehra MR, Ventura HO, Smart FW, Stapleton DD
Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside. J Heart Lung Transplant. 1995 Nov-Dec; 14(6 Pt 2):S246-9.
Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O'Connor CM, Reynolds D, Walsh MN
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol. 2010 Jun 15; 105(12):1773-9.
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF).
Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA
International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010 Jul; 29(7):717-27.
International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.
Current and future challenges in therapy for antibody-mediated rejection. J Heart Lung Transplant. 2011 Jun; 30(6):612-7.
Current and future challenges in therapy for antibody-mediated rejection.
Pang PS, Mehra M, Maggioni AP, Filippatos G, Middlebrooks J, Turlapaty P, Kazei D, Gheorghiade M
Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure. Am Heart J. 2011 Jun; 161(6):1012-23.e3.
Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure.
Utility of heart biopsy in transplant patients. Ochsner J. 2001 Oct; 3(4):219-22.
Utility of heart biopsy in transplant patients.
Greenberg B, Fang J, Mehra M, Stevenson LW
Advanced heart failure: Trans-Atlantic perspectives on the Heart Failure Association of the European Society of Cardiology position statement. Eur J Heart Fail. 2018 11; 20(11):1536-1539.
Advanced heart failure: Trans-Atlantic perspectives on the Heart Failure Association of the European Society of Cardiology position statement.
Advancing from a "hemodynamic model" to a "mechanistic disease-modifying model" of cardiogenic shock. J Heart Lung Transplant. 2018 11; 37(11):1285-1288.
Advancing from a "hemodynamic model" to a "mechanistic disease-modifying model" of cardiogenic shock.
Milani RV, Lavie CJ, Mehra MR, Ventura HO
Exercise training as treatment of depression in heart failure. J Am Coll Cardiol. 2012 Jan 17; 59(3):291.
Exercise training as treatment of depression in heart failure.
Should left ventricular assist device should be standard of care for patients with refractory heart failure who are not transplantation candidates?: left ventricular assist devices should be considered standard of care for patients with refractory heart failure who are not transplantation candidates. Circulation. 2012 Dec 18; 126(25):3081-7.
Should left ventricular assist device should be standard of care for patients with refractory heart failure who are not transplantation candidates?: left ventricular assist devices should be considered standard of care for patients with refractory heart failure who are not transplantation candidates.
Nemer DM, Stewart GC, Puligandla M, Neuberg DS, Givertz MM, Mehra MR, Couper GS, Connors JM
Postoperative bridging anticoagulation and left ventricular assist system thrombosis. J Thromb Thrombolysis. 2019 Jan; 47(1):57-66.
Postoperative bridging anticoagulation and left ventricular assist system thrombosis.
Mehra MR, Salerno C, Naka Y, Uriel N, Cleveland JC, Horstmanshof D, Goldstein DJ
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 11; 37(11):1281-1284.
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial.
Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol. 2004 Mar 01; 93(5):588-93.
Peak exercise oxygen pulse and prognosis in chronic heart failure.
Eisen HJ, Kobashigawa J, Keogh A, Bourge R, Renlund D, Mentzer R, Alderman E, Valantine H, Dureau G, Mancini D, Mamelok R, Gordon R, Wang W, Mehra M, Constanzo MR, Hummel M, Johnson J
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant. 2005 May; 24(5):517-25.
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.
Ventricular assist devices: destination therapy or just another stop on the road? Curr Heart Fail Rep. 2004 Apr-May; 1(1):36-40.
Ventricular assist devices: destination therapy or just another stop on the road?
Optimizing outcomes in the patient with acute decompensated heart failure. Am Heart J. 2006 Mar; 151(3):571-9.
Optimizing outcomes in the patient with acute decompensated heart failure.
Milani RV, Lavie CJ, Mehra MR, Ventura HO, Kurtz JD, Messerli FH
Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006 Apr 01; 97(7):959-63.
Left ventricular geometry and survival in patients with normal left ventricular ejection fraction.
Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis. Congest Heart Fail. 2007 Nov-Dec; 13(6):319-22.
Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis.
Stehlik J, Chambers DC, Zuckermann A, Mehra MR, Khush KK
Increasing complexity of thoracic transplantation and the rise of multiorgan transplantation around the world: Insights from the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant. 2018 10; 37(10):1145-1154.
Increasing complexity of thoracic transplantation and the rise of multiorgan transplantation around the world: Insights from the International Society for Heart and Lung Transplantation Registry.
Left ventricular assist device use in biventricular configurations: It takes two to tango. J Heart Lung Transplant. 2018 12; 37(12):1391-1393.
Left ventricular assist device use in biventricular configurations: It takes two to tango.
Response by Netuka et al regarding the article "Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study". J Heart Lung Transplant. 2018 10; 37(10):1279-1280.
Response by Netuka et al regarding the article "Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study".
Mehra MR, Ventura HO, Stapleton DD, Karsan AK, Smart FW, Ramee SR, Collins TJ
Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy. Am Heart J. 1997 Jun; 133(6):698-702.
Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.
Manord JD, Garrard CL, Mehra MR, Sternbergh WC, Ballinger B, Ventura HO, Stapleton DD, Smart FW, Bowen JC, Money SR
Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. J Vasc Surg. 1997 Sep; 26(3):511-5; discussion 515-6.
Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation.
Escobar A, Ventura HO, Stapleton DD, Mehra MR, Ramee SR, Collins TJ, Jain SP, Smart FW, White CJ
Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. Am J Cardiol. 1994 Nov 15; 74(10):1042-6.
Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.
Adams KF, Patterson JH, Patterson JH, Oren RM, Mehra MR, O'Connor CM, Piña IL, Miller AB, Chiong JR, Dunlap SH, Cotts WG, Felker GM, Schocken DD, Schwartz TA, Ghali JK
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Am Heart J. 2009 May; 157(5):926-32.
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry.
Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010 Mar; 3(2):314-25.
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.
O'Connor CM, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, Reynolds D, Walsh MN, Yancy CW, Fonarow GC
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). Am J Cardiol. 2011 Jan 15; 107(2):250-8.
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial).
Ambrosy AP, Fonarow GC, Albert NM, Curtis AB, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Gheorghiade M
Journal of cardiovascular medicine (Hagerstown, Md.)
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7.
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF.
Gilstrap LG, Stevenson LW, Small R, Parambi R, Hamershock R, Greenberg J, Carr C, Ghazinouri R, Rathman L, Han E, Mehra MR, Desai AS
Journal of the American Heart Association
Reasons for Guideline Nonadherence at Heart Failure Discharge. J Am Heart Assoc. 2018 08 07; 7(15):e008789.
Reasons for Guideline Nonadherence at Heart Failure Discharge.
Prasad A, Mehra M, Park M, Scott R, Uber PA, McFadden PM
Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease. Ann Thorac Surg. 1999 Nov; 68(5):1840-1.
Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease.
The American journal of the medical sciences
Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts. Am J Med Sci. 2002 Nov; 324(5):267-75.
Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts.
Clopidogrel and rhabdomyolysis after heart transplantation. J Heart Lung Transplant. 2003 Jan; 22(1):107-8.
Clopidogrel and rhabdomyolysis after heart transplantation.
The growing burden of heart failure: the "syndemic" is reaching Latin America. Am Heart J. 2004 Mar; 147(3):386-9.
The growing burden of heart failure: the "syndemic" is reaching Latin America.
Park MH, Scott RL, Uber PA, Ventura HO, Mehra MR
Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. Congest Heart Fail. 2004 Sep-Oct; 10(5):221-5.
Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension.
Nachimuthu S, Uber PA, Balasundaram P, Mehra MR
CHF: "compressive" heart failure? A clinical review of metastatic cardiac tumors. Congest Heart Fail. 2004 Sep-Oct; 10(5):254-6.
CHF: "compressive" heart failure? A clinical review of metastatic cardiac tumors.
Potluri SP, Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO
Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation. J Heart Lung Transplant. 2005 Aug; 24(8):1019-25.
Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation.
Prediction of optimal outcomes in organ transplantation. Intensive Care Med. 2019 03; 45(3):367-370.
Prediction of optimal outcomes in organ transplantation.
Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database. Am J Hypertens. 1993 Nov; 6(11 Pt 2):340S-345S.
Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database.
Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia. Drugs. 1994; 47 Suppl 2:64-72.
Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia.
Mehra MR, Ventura HO, Escobar A, Cassidy CA, Smart FW, Stapleton DD
Does donor and recipient sex influence the development of cardiac allograft vasculopathy? Transplant Proc. 1995 Jun; 27(3):1926-9.
Does donor and recipient sex influence the development of cardiac allograft vasculopathy?
Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable. Eur J Heart Fail. 2019 01; 21(1):98-100.
Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable.
B-type natriuretic peptide in heart failure: diagnostic, prognostic, and therapeutic use. Crit Pathw Cardiol. 2005 Mar; 4(1):10-20.
B-type natriuretic peptide in heart failure: diagnostic, prognostic, and therapeutic use.
Walsh MN, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Yancy CW, Fonarow GC
Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clin Cardiol. 2012 Mar; 35(3):187-96.
Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices.
Groarke JD, Mahmood SS, Payne D, Ganatra S, Hainer J, Neilan TG, Partridge AH, Di Carli MF, Jones LW, Mehra MR, Nohria A
Case-control study of heart rate abnormalities across the breast cancer survivorship continuum. Cancer Med. 2019 01; 8(1):447-454.
Case-control study of heart rate abnormalities across the breast cancer survivorship continuum.
Colombo PC, Mehra MR, Goldstein DJ, Estep JD, Salerno C, Jorde UP, Cowger JA, Cleveland JC, Uriel N, Sayer G, Skipper ER, Downey FX, Ono M, Hooker R, Anyanwu AC, Givertz MM, Mahr C, Topuria I, Somo SI, Crandall DL, Horstmanshof DA
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 01 08; 139(2):155-168.
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Mehra MR, Lavie CJ, Ventura HO, Milani RV
Prevention of atherosclerosis. The potential role of antioxidants. Postgrad Med. 1995 Jul; 98(1):175-6, 179-84.
Prevention of atherosclerosis. The potential role of antioxidants.
DeFilippis EM, Vaduganathan M, Machado S, Stehlik J, Mehra MR
Emerging Trends in Financing of Adult Heart Transplantation in the United States. JACC Heart Fail. 2019 01; 7(1):56-62.
Emerging Trends in Financing of Adult Heart Transplantation in the United States.
Ali A, Mehra MR, Malik FS, Uber PA, Ventura HO
Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy. Am J Cardiol. 2001 Feb 01; 87(3):367-8, A10.
Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy.
Bloodletting as a cure for dropsy: heart failure down the ages. J Card Fail. 2005 May; 11(4):247-52.
Bloodletting as a cure for dropsy: heart failure down the ages.
Johnson MR, Aaronson KD, Canter CE, Kirklin JK, Mancini DM, Mehra MR, Radovancevic B, Taylor DO, Webber SA
Heart retransplantation. Am J Transplant. 2007 Sep; 7(9):2075-81.
HDL and Heart Failure Regulation: Still Breathing but Exhausted. J Am Coll Cardiol. 2019 01 22; 73(2):187-189.
HDL and Heart Failure Regulation: Still Breathing but Exhausted.
O'Connell JB, McCarthy PM, Sopko G, Filippatos GS, Piña IL, Konstam MA, Young JB, Miller LW, Mehra MR, Roland E, Blair JE, Farrar DJ, Gheorghiade M
Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design. Heart Fail Rev. 2009 Jun; 14(2):101-12.
Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design.
Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010 Feb; 85(2):180-95.
Chronic heart failure: contemporary diagnosis and management.
Shukla A, Curtis AB, Mehra MR, Albert NM, Gheorghiade M, Heywood JT, Liu Y, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF. Pacing Clin Electrophysiol. 2013 Apr; 36(4):433-43.
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF.
Imamura T, Jeevanandam V, Kim G, Raikhelkar J, Sarswat N, Kalantari S, Smith B, Rodgers D, Besser S, Chung B, Nguyen A, Narang N, Ota T, Song T, Juricek C, Mehra M, Costanzo MR, Jorde UP, Burkhoff D, Sayer G, Uriel N
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circ Heart Fail. 2019 02; 12(2):e005094.
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.
Vaduganathan M, Machado SR, DeFilippis EM, Bajaj N, Stehlik J, Mossialos E, Jarcho JA, Mehra MR
Organ Donation and Drug Intoxication-Related Deaths in the United States. N Engl J Med. 2019 02 07; 380(6):597-599.
Organ Donation and Drug Intoxication-Related Deaths in the United States.
Desai AS, Schaefer KG, Tulsky JA, Mehra MR
Quality of death after left ventricular assist device implantation: More questions than answers. J Heart Lung Transplant. 2019 04; 38(4):382-384.
Quality of death after left ventricular assist device implantation: More questions than answers.
In reply-Mona Lisa and Postpartum Hypothyroidism. Mayo Clin Proc. 2019 03; 94(3):544-545.
In reply-Mona Lisa and Postpartum Hypothyroidism.
Mehra MR, Uriel N, Naka Y, Cleveland JC, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
Kumar A, Mehra M, Singh S, Badhan SK, Gulati N
Teachers' awareness and opinion about AIDS: implications for school based AIDS education. J Commun Dis. 1995 Jun; 27(2):101-6.
Teachers' awareness and opinion about AIDS: implications for school based AIDS education.
Levesque AA, Lewin AR, Rimsans J, Sylvester KW, Coakley L, Melanson F, Mallidi H, Mehra M, Givertz MM, Connors JM
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619837362.
Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support.
Carnicelli AP, Thakkar A, Deicicchi DJ, Storm AC, Rimsans J, Connors JM, Mehra MR, Groarke JD, Givertz MM
Resource utilization and hospital readmission associated with gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices. J Thromb Thrombolysis. 2019 Apr; 47(3):375-383.
Resource utilization and hospital readmission associated with gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices.
Woolley AE, Singh SK, Goldberg HJ, Mallidi HR, Givertz MM, Mehra MR, Coppolino A, Kusztos AE, Johnson ME, Chen K, Haddad EA, Fanikos J, Harrington DP, Camp PC, Baden LR
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients. N Engl J Med. 2019 04 25; 380(17):1606-1617.
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
In reply-The Mona Lisa Decrypted: Another Premise. Mayo Clin Proc. 2019 04; 94(4):731-732.
In reply-The Mona Lisa Decrypted: Another Premise.
Bobenko A, Schoenrath F, Knierim JH, Friede T, Verheyen N, Mehra MR, Haykowsky M, Herrmann-Lingen C, Duvinage A, Pieske-Kraigher E, Halle M, Falk V, Pieske B, Edelmann F
Exercise training in patients with a left ventricular assist device (Ex-VAD): rationale and design of a multicentre, prospective, assessor-blinded, randomized, controlled trial. Eur J Heart Fail. 2019 09; 21(9):1152-1159.
Exercise training in patients with a left ventricular assist device (Ex-VAD): rationale and design of a multicentre, prospective, assessor-blinded, randomized, controlled trial.
Bajaj NS, Vaduganathan M, Qamar A, Gupta K, Gupta A, Golwala H, Butler J, Goldhaber SZ, Mehra MR
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis. PLoS Med. 2019 04; 16(4):e1002797.
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis.
Greenberg B, Neaton JD, Anker SD, Byra WM, Cleland JGF, Deng H, Fu M, La Police DA, Lam CSP, Mehra MR, Nessel CC, Spiro TE, van Veldhuisen DJ, Vanden Boom CM, Zannad F
Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial. JAMA Cardiol. 2019 06 01; 4(6):515-523.
Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.
Kulkarni A, Patel N, Singh TP, Mossialos E, Mehra MR
Risk factors for death or heart transplantation in single-ventricle physiology (tricuspid atresia, pulmonary atresia, and heterotaxy): A systematic review and meta-analysis. J Heart Lung Transplant. 2019 07; 38(7):739-747.
Risk factors for death or heart transplantation in single-ventricle physiology (tricuspid atresia, pulmonary atresia, and heterotaxy): A systematic review and meta-analysis.
Almarzooq Z, Pareek M, Sinnenberg L, Vaduganathan M, Mehra MR
Nine contemporary therapeutic directions in heart failure. Heart Asia. 2019; 11(1):e011150.
Nine contemporary therapeutic directions in heart failure.
Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J
Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant. 2019 08; 38(8):858-869.
Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices.
Bansal A, Uriel N, Colombo PC, Narisetty K, Long JW, Bhimaraj A, Cleveland JC, Goldstein DJ, Stulak JM, Najjar SS, Lanfear DE, Adler ED, Dembitsky WP, Somo SI, Crandall DL, Chen D, Connors JM, Mehra MR
Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial. J Heart Lung Transplant. 2019 08; 38(8):806-816.
Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
Lindenfeld J, Abraham WT, Maisel A, Zile M, Smart F, Costanzo MR, Mehra MR, Ducharme A, Sears SF, Desai AS, Paul S, Sood P, Johnson N, Ginn G, Adamson PB
Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF). Am Heart J. 2019 08; 214:18-27.
Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF).
Connors JM, Gregor S, Crandall D, Netuka I, Mehra MR
Low-intensity anti-coagulation using Vitamin K antagonists and Factor X activity: A validation analysis of the MAGENTUM-1 study. J Heart Lung Transplant. 2019 06; 38(6):668-669.
Low-intensity anti-coagulation using Vitamin K antagonists and Factor X activity: A validation analysis of the MAGENTUM-1 study.
Divakaran S, Stewart GC, Lakdawala NK, Padera RF, Zhou W, Desai AS, Givertz MM, Mehra MR, Kwong RY, Hedgire SS, Ghoshhajra BB, Taqueti VR, Skali H, Dorbala S, Blankstein R, Di Carli MF
Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.
Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device. Trends Cardiovasc Med. 2020 05; 30(4):223-229.
Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device.
Cardiac CT to Diagnose Left Ventricular Assist Device Outflow Graft Twist. Radiology. 2019 09; 292(3):537.
Cardiac CT to Diagnose Left Ventricular Assist Device Outflow Graft Twist.
Imaging the Crevasse of Left Ventricular Assist Device Infection. JACC Cardiovasc Imaging. 2020 05; 13(5):1203-1205.
Imaging the Crevasse of Left Ventricular Assist Device Infection.
Response by Mehra and Colombo to Letter Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump". Circulation. 2019 07 23; 140(4):e165-e166.
Response by Mehra and Colombo to Letter Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".
Magnetically Levitated Left Ventricular Assist Device. Reply. N Engl J Med. 2019 08 01; 381(5):490.
Magnetically Levitated Left Ventricular Assist Device. Reply.
Mehra MR, Vaduganathan M, Fu M, Ferreira JP, Anker SD, Cleland JGF, Lam CSP, van Veldhuisen DJ, Byra WM, Spiro TE, Deng H, Zannad F, Greenberg B
A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J. 2019 11 21; 40(44):3593-3602.
A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Adoption of hepatitis C virus-infected donor hearts: A "middle child" no more. J Heart Lung Transplant. 2019 09; 38(9):918-919.
Adoption of hepatitis C virus-infected donor hearts: A "middle child" no more.
Almarzooq ZI, Varshney AS, Vaduganathan M, Pareek M, Stewart GC, Estep JD, Mehra MR
Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support. JACC Cardiovasc Imaging. 2020 04; 13(4):1069-1081.
Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support.
Kransdorf EP, Patterson CM, Mehra MR, Stehlik J
Donor-recipient size match in thoracic transplantation: back to fundamentals. J Heart Lung Transplant. 2019 10; 38(10):1007-1014.
Donor-recipient size match in thoracic transplantation: back to fundamentals.
Reply to Geisen et al, Acquired von Willebrand syndrome and left ventricular assist devices. J Heart Lung Transplant. 2020 01; 39(1):89-90.
Reply to Geisen et al, Acquired von Willebrand syndrome and left ventricular assist devices.
Buckley LF, Stevenson LW, Cooper IM, Knowles DM, Matta L, Molway DW, Navarro-Velez K, Rhoten MN, Shea EL, Stern GM, Weintraub JR, Young MA, Mehra MR, Desai AS
Ambulatory Treatment of Worsening Heart Failure With Intravenous Loop Diuretics: A Four-Year Experience. J Card Fail. 2020 09; 26(9):798-799.
Ambulatory Treatment of Worsening Heart Failure With Intravenous Loop Diuretics: A Four-Year Experience.
Khan MS, Irfan S, Khan SU, Mehra MR, Vaduganathan M
Transforming the interpretation of significance in heart failure trials. Eur J Heart Fail. 2020 02; 22(2):177-180.
Transforming the interpretation of significance in heart failure trials.
Long-Term Survival After Heart Transplantation at Centers Stratified by Short-Term Performance. Circ Heart Fail. 2019 11; 12(11):e005914.
Long-Term Survival After Heart Transplantation at Centers Stratified by Short-Term Performance.
Cogswell R, John R, Estep JD, Duval S, Tedford RJ, Pagani FD, Martin CM, Mehra MR
An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. J Heart Lung Transplant. 2020 01; 39(1):1-4.
An early investigation of outcomes with the new 2018 donor heart allocation system in the United States.
London School of Economics, Healthcare Economics and Management
Harvard Business School, Executive Leadership in Healthcare
Royal College of Physicians, FRCP (Honorary)
Reappraisal of the safety and effectiveness of Impella pumps. Nat Rev Cardiol. 2020 04; 17(4):203-204.
Reappraisal of the safety and effectiveness of Impella pumps.
Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. JAMA Cardiol. 2020 04 01; 5(4):411-419.
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Heart Failure With Preserved Ejection Fraction: Separating the Wheat From the Chaff. J Am Coll Cardiol. 2020 01 28; 75(3):255-257.
Heart Failure With Preserved Ejection Fraction: Separating the Wheat From the Chaff.
WITHDRAWN: Anticoagulation management strategies in heart transplantation. Prog Cardiovasc Dis. 2020 Jan 31.
WITHDRAWN: Anticoagulation management strategies in heart transplantation.
Anticoagulation management strategies in heart transplantation. Prog Cardiovasc Dis. 2020 May - Jun; 63(3):210-218.
Anticoagulation management strategies in heart transplantation.
Rhabdomyolysis with the combined use of danazol and rosuvastatin in left ventricular assist devices. J Heart Lung Transplant. 2020 05; 39(5):498-500.
Rhabdomyolysis with the combined use of danazol and rosuvastatin in left ventricular assist devices.
Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal. J Am Coll Cardiol. 2020 04 14; 75(14):1657-1658.
Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal.
Cunningham JW, Ferreira JP, Deng H, Anker SD, Byra WM, Cleland JGF, Gheorghiade M, Lam CSP, La Police D, Mehra MR, Neaton JD, Spiro TE, van Veldhuisen DJ, Greenberg B, Zannad F
Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF. JACC Heart Fail. 2020 05; 8(5):359-368.
Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF.
Groarke JD, Payne DL, Claggett B, Mehra MR, Gong J, Caron J, Mahmood SS, Hainer J, Neilan TG, Partridge AH, Di Carli M, Jones LW, Nohria A
European heart journal. Quality of care & clinical outcomes
Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):315-322.
Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer.
Gut dysbiosis and heart failure: navigating the universe within. Eur J Heart Fail. 2020 04; 22(4):629-637.
Gut dysbiosis and heart failure: navigating the universe within.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2020 03 05; 382(10):972-973.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
European journal of preventive cardiology
Hypokalemia in heart failure: A low or a high point? Eur J Prev Cardiol. 2020 Mar 22; 2047487320914745.
Hypokalemia in heart failure: A low or a high point?
Mallah SI, Atallah B, Moustafa F, Naguib M, El Hajj S, Bader F, Mehra MR
Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy. Prog Cardiovasc Dis. 2020 May - Jun; 63(3):194-209.
Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy.
Vieira JL, Pfeffer M, Claggett BL, Stewart GC, Givertz MM, Coakley L, Mallidi HR, Mehra MR
The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure. J Heart Lung Transplant. 2020 06; 39(6):582-592.
The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure.
COVID-19: Yet another coronavirus challenge in transplantation. J Heart Lung Transplant. 2020 05; 39(5):408-409.
COVID-19: Yet another coronavirus challenge in transplantation.
Daud A, Mehra MR, Siu A, Johnson MR, Perch M, Budev M, Zakharia Y, Cheng R, Nativi-Nicolau J, Stehlik J
Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative. J Heart Lung Transplant. 2020 06; 39(6):604-606.
Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative.
Patel CB, Blue L, Cagliostro B, Bailey SH, Entwistle JW, John R, Thohan V, Cleveland JC, Goldstein DJ, Uriel N, Su X, Somo SI, Sood P, Mehra MR
Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 08; 39(8):774-781.
Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
Kanwar MK, Rajagopal K, Itoh A, Silvestry SC, Uriel N, Cleveland JC, Salerno CT, Horstmanshof D, Goldstein DJ, Naka Y, Bailey S, Gregoric ID, Chuang J, Sood P, Mehra MR
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H
Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020 05 02; 395(10234):1417-1418.
Endothelial cell infection and endotheliitis in COVID-19.
The heart-gut microbiome axis in advanced heart failure. J Heart Lung Transplant. 2020 09; 39(9):891-893.
The heart-gut microbiome axis in advanced heart failure.
Bariatric surgery and heart transplantation outcomes: A note of caution. J Heart Lung Transplant. 2020 09; 39(9):986-987.
Bariatric surgery and heart transplantation outcomes: A note of caution.
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020 06 18; 382(25):e102.
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
Saeed O, Colombo PC, Mehra MR, Uriel N, Goldstein DJ, Cleveland J, Connors JM, Najjar SS, Mokadam NA, Bansal A, Crandall DL, Sood P, Jorde UP
Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study. J Heart Lung Transplant. 2020 06; 39(6):518-525.
Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study.
Almufleh A, Desai AS, Fay R, Ferreira JP, Buckley LF, Mehra MR, Rossignol P, Zannad F
Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients. Eur J Heart Fail. 2020 10; 22(10):1907-1911.
Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients.
Dilemma of organ donation in transplantation and the COVID-19 pandemic. J Heart Lung Transplant. 2020 05; 39(5):410-411.
Dilemma of organ donation in transplantation and the COVID-19 pandemic.
COVID-19 Illness and Heart Failure: A Missing Link? JACC Heart Fail. 2020 06; 8(6):512-514.
COVID-19 Illness and Heart Failure: A Missing Link?
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer
Clearance of parenterally administered 203Hg from the mouse tissues. J Environ Pathol Toxicol Oncol. 1984 Jul; 5(4-5):127-30.
Clearance of parenterally administered 203Hg from the mouse tissues.
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020 05; 39(5):405-407.
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.
Aslam S, Grossi P, Schlendorf KH, Holm AM, Woolley AE, Blumberg E, Mehra MR
Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant. 2020 05; 39(5):418-432.
Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel A, Mehra MR, Scholkmann F, Schüpbach R, Ruschitzka F, Moch H
Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply. Lancet. 2020 05 30; 395(10238):e100.
Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
Cross SH, Mehra MR, Bhatt DL, Nasir K, O'Donnell CJ, Califf RM, Warraich HJ
Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017. JAMA. 2020 05 12; 323(18):1852-1854.
Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017.
Special Article - Palliative care considerations for cardiovascular clinicians in COVID-19. Prog Cardiovasc Dis. 2020 Sep-Oct; 63(5):696-698.
Special Article - Palliative care considerations for cardiovascular clinicians in COVID-19.
Vaduganathan M, van Meijgaard J, Mehra MR, Joseph J, O'Donnell CJ, Warraich HJ
Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States. JAMA. 2020 06 23; 323(24):2524-2526.
Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.
Mehra MR, Desai SS, Ruschitzka F, Patel AN
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 05 22.
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Saeed O, Columbo PC, Mehra MR, Uriel N, Goldstein DJ, Cleveland JC, Conners JM, Najjar SS, Mokadam NA, Bansal A, Crandall DL, Sood P, Jorde UP
The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial. J Heart Lung Transplant. 2020 Apr; 39(4S):S47.
The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial.
Daud A, Mehra MR, Siu A, Johnson MR, Perch M, Budev M, Zakharia Y, Cheng R, Stehlik J
Immune Checkpoint Inhibitors in Thoracic Transplant Recipients: A Registry Initiative. J Heart Lung Transplant. 2020 Apr; 39(4S):S210.
Immune Checkpoint Inhibitors in Thoracic Transplant Recipients: A Registry Initiative.
Patel CB, Bailey SH, Blue L, Cagliostro B, Entwistle JW, John R, Thohan V, Su X, Somo SI, Sood P, Mehra MR
Infection-Related Morbidity with Continuous-Flow Left Ventricular Assist Systems: A Comprehensive Analysis of the Randomized MOMENTUM 3 Trial. J Heart Lung Transplant. 2020 Apr; 39(4S):S45.
Infection-Related Morbidity with Continuous-Flow Left Ventricular Assist Systems: A Comprehensive Analysis of the Randomized MOMENTUM 3 Trial.
Kim M, Givertz MM, Stewart GC, Page DS, Woodcome EL, Mehra MR, Mehra MR
Efficacy and Safety of LCP-Tacrolimus (Envarsus XR®) Conversion Therapy in Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39(4S):S502.
Efficacy and Safety of LCP-Tacrolimus (Envarsus XR®) Conversion Therapy in Heart Transplantation.
Kanwar M, Rajagopal K, Itoh A, Silvestry SC, Uriel N, Cleveland JC, Salerno CT, Horstmanshof D, Goldstein DJ, Naka Y, Bailey S, Gregoric ID, Chuang J, Sood P, Mehra MR
Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study. J Heart Lung Transplant. 2020 Apr; 39(4S):S116.
Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study.
Vieira JL, Cherikh WS, Lindblad K, Stehlik J, Mehra MR
Cocaine Use in Organ Donors and Long-Term Outcome after Heart Transplantation: An ISHLT Registry Analysis. J Heart Lung Transplant. 2020 Apr; 39(4S):S43.
Cocaine Use in Organ Donors and Long-Term Outcome after Heart Transplantation: An ISHLT Registry Analysis.
Blumenthal-Barby JS, Kostick KM, Trejo M, Bhimaraj A, Civitello A, Horstmanshof DA, Jorde UP, Loebe M, Mehra MR, Thohan V, Trachtenberg BH, Uriel N, Volk RJ, Estep JD
Implementation of Patient-Centered Shared Decision Making for LVAD Candidates: Year 1 Results of a Multi-Site Study. J Heart Lung Transplant. 2020 Apr; 39(4S):S159.
Implementation of Patient-Centered Shared Decision Making for LVAD Candidates: Year 1 Results of a Multi-Site Study.
Vieira JL, Pfeffer M, Claggett B, Connors J, Stewart GC, Givertz MM, Coakley L, Mallidi HR, Mehra MR
The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems. J Heart Lung Transplant. 2020 Apr; 39(4S):S26-S27.
The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems.
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621. N Engl J Med. 2020 06 25; 382(26):2582.
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
A study of ocular infections amongst primary school children in Delhi. J Commun Dis. 2004 Jun; 36(2):121-6.
A study of ocular infections amongst primary school children in Delhi.
Prevalence of paralytic poliomyelitis in a rural and urban community of Delhi. Indian Pediatr. 1990 Sep; 27(9):915-7.
Prevalence of paralytic poliomyelitis in a rural and urban community of Delhi.
Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi E, Bozkurt B, Braunwald E, Chopra VK, Cleland JG, Ezekowitz J, Filippatos G, Friede T, Hernandez AF, Lam CSP, Lindenfeld J, McMurray JJV, Mehra M, Metra M, Packer M, Pieske B, Pocock SJ, Ponikowski P, Rosano GMC, Teerlink JR, Tsutsui H, Van Veldhuisen DJ, Verma S, Voors AA, Wittes J, Zannad F, Zhang J, Seferovic P, Coats AJS
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2020 06 07; 41(22):2109-2117.
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Holm AM, Mehra MR, Courtwright A, Teuteberg J, Sweet S, Potena L, Singer LG, Farrero M, Shullo MA, Benza R, Ensminger S, Aslam S
Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement. J Heart Lung Transplant. 2020 07; 39(7):619-626.
Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement.
Farmakis D, Mehra MR, Parissis J, Filippatos G
Heart failure in the course of a pandemic. Eur J Heart Fail. 2020 10; 22(10):1755-1758.
Heart failure in the course of a pandemic.
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 06 13; 395(10240):1820.
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Almufleh A, Ahluwalia M, Givertz MM, Weintraub J, Young M, Cooper I, Shea EL, Mehra MR, Desai AS
Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring. J Card Fail. 2020 07; 26(7):633-634.
Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring.
Microbiota and Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020 06 11; 382(24):2378.
Microbiota and Allogeneic Hematopoietic-Cell Transplantation.
Untimely Trial Publication: A Sin of Omission? J Am Coll Cardiol. 2020 06 30; 75(25):3162-3163.
Untimely Trial Publication: A Sin of Omission?
A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19. Clin Transplant. 2020 11; 34(11):e14032.
A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19.
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW
Extrapulmonary manifestations of COVID-19. Nat Med. 2020 07; 26(7):1017-1032.
Extrapulmonary manifestations of COVID-19.
Manka R, Karolyi M, Polacin M, Holy EW, Nemeth J, Steiger P, Schuepbach RA, Zinkernagel AS, Alkadhi H, Mehra MR, Ruschitzka F
Myocardial edema in COVID-19 on cardiac MRI. J Heart Lung Transplant. 2020 07; 39(7):730-732.
Myocardial edema in COVID-19 on cardiac MRI.
Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020 07; 95(7):1445-1453.
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.
Kaufman CL, Kanitakis J, Weissenbacher A, Brandacher G, Mehra MR, Amer H, Zelger BG, Zelger B, Pomahac B, McDiarmid S, Cendales L, Morelon E
Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation. SAGE Open Med. 2020; 8:2050312120940421.
Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.
Rizk JG, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Forthal DN
Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs. 2020 Sep; 80(13):1267-1292.
Pharmaco-Immunomodulatory Therapy in COVID-19.
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19". Drugs. 2020 09; 80(14):1501-1503.
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19".
Secular changes in organ donor profiles and impact on heart and lung transplantation. J Heart Lung Transplant. 2020 10; 39(10):997-1002.
Secular changes in organ donor profiles and impact on heart and lung transplantation.
Ferreira JP, Lam CSP, Anker SD, Mehra MR, van Veldhuisen DJ, Byra WM, La Police DA, Cleland JGF, Greenberg B, Zannad F
Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial. Eur J Heart Fail. 2021 04; 23(4):648-656.
Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial.
Cocaine use in organ donors and long-term outcome after heart transplantation: An International Society for Heart and Lung Transplantation registry analysis. J Heart Lung Transplant. 2020 12; 39(12):1341-1350.
Cocaine use in organ donors and long-term outcome after heart transplantation: An International Society for Heart and Lung Transplantation registry analysis.
Sivathasan C, Hayward C, Jansz P, Sibal AK, Cally HKL, Balakrishnan KR, Cho YH, Nordin MN, Barril JB, Khaliel F, Mehra MR
Durable mechanical circulatory support across the Asia-Pacific region. J Heart Lung Transplant. 2020 11; 39(11):1195-1198.
Durable mechanical circulatory support across the Asia-Pacific region.
Redefining Left Ventricular Assist Device Indications and Strategies-Reply. JAMA Cardiol. 2021 01 01; 6(1):120-121.
Redefining Left Ventricular Assist Device Indications and Strategies-Reply.
Mechanical circulatory support devices in advanced heart failure: 2020 and beyond. Prog Cardiovasc Dis. 2020 Sep - Oct; 63(5):630-639.
Mechanical circulatory support devices in advanced heart failure: 2020 and beyond.
Elagizi A, Carbone S, Lavie CJ, Mehra MR, Ventura HO
Implications of obesity across the heart failure continuum. Prog Cardiovasc Dis. 2020 Sep - Oct; 63(5):561-569.
Implications of obesity across the heart failure continuum.
Transcatheter mitral valve intervention in advanced heart failure. J Heart Lung Transplant. 2020 12; 39(12):1363-1365.
Transcatheter mitral valve intervention in advanced heart failure.
Chung M, Cabezas FR, Nunez JI, Kennedy KF, Rick K, Rycus P, Mehra MR, Garan AR, Kociol RD, Grandin EW
Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis. JACC Heart Fail. 2020 11; 8(11):892-902.
Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis.
Sinnenberg L, Machado SR, Ostrominski JW, Stehlik J, Mehra MR, Vaduganathan M
Citizenship Status and Cardiothoracic Organ Transplantation in the United States. Circ Heart Fail. 2020 12; 13(12):e007788.
Citizenship Status and Cardiothoracic Organ Transplantation in the United States.
Varshney AS, Wang DE, Bhatt AS, Blood A, Sharkawi MA, Siddiqi HK, Vaduganathan M, Monteleone PP, Patel MR, Jones WS, Lopes RD, Mehra MR, Bhatt DL, Kochar A
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis. Am Heart J. 2021 02; 232:105-115.
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015. JAMA Netw Open. 2020 11 02; 3(11):e2023515.
Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015.
Anker MS, Sanz AP, Zamorano JL, Mehra MR, Butler J, Riess H, Coats AJS, Anker SD
Advanced cancer is also a heart failure syndrome: a hypothesis. Eur J Heart Fail. 2021 01; 23(1):140-144.
Advanced cancer is also a heart failure syndrome: a hypothesis.
Rizk JG, Forthal DN, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Pfeiffer JP, Lewin JC
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. Drug Discov Today. 2021 02; 26(2):593-603.
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
Current opinion in organ transplantation
Heart transplantation candidacy. Curr Opin Organ Transplant. 2021 02 01; 26(1):69-76.
Harms HJ, Bravo PE, Bajaj NS, Zhou W, Gupta A, Tran T, Taqueti VR, Hainer J, Bibbo C, Dorbala S, Blankstein R, Mehra M, Sörensen J, Givertz MM, Di Carli MF
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2022 06; 29(3):1234-1244.
Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients.
Ferreira JP, Cleland JGF, Lam CSP, van Veldhuisen DJ, Byra WM, La Police DA, Anker SD, Mehra MR, Leroy C, Eschwege V, Toussaint-Hacquard M, Rossignol P, Greenberg B, Zannad F
Impact of Geographic Region on the COMMANDER-HF Trial. JACC Heart Fail. 2021 03; 9(3):201-211.
Impact of Geographic Region on the COMMANDER-HF Trial.
Hypokalemia in heart failure: A low or a high point? Eur J Prev Cardiol. 2021 Apr 23; 28(3):313-315.
Ferreira JP, Cleland JG, Lam CSP, Anker SD, Mehra MR, van Veldhuisen DJ, Byra WM, La Police DA, Pitt B, Greenberg B, Zannad F
Clinical research in cardiology : official journal of the German Cardiac Society
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE. Clin Res Cardiol. 2021 Oct; 110(10):1554-1563.
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE.
Journal of cachexia, sarcopenia and muscle
Advanced cancer is also a heart failure syndrome: a hypothesis. J Cachexia Sarcopenia Muscle. 2021 06; 12(3):533-537.
Coats AJS, Anker SD, Baumbach A, Alfieri O, von Bardeleben RS, Bauersachs J, Bax JJ, Boveda S, Celutkiene J, Cleland JG, Dagres N, Deneke T, Farmakis D, Filippatos G, Hausleiter J, Hindricks G, Jankowska EA, Lainscak M, Leclercq C, Lund LH, McDonagh T, Mehra MR, Metra M, Mewton N, Mueller C, Mullens W, Muneretto C, Obadia JF, Ponikowski P, Praz F, Rudolph V, Ruschitzka F, Vahanian A, Windecker S, Zamorano JL, Edvardsen T, Heidbuchel H, Seferovic PM, Prendergast B
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur Heart J. 2021 Mar 31; 42(13):1254-1269.
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
Kostick KM, Trejo M, Bhimaraj A, Civitello A, Grinstein J, Horstmanshof D, Jorde UP, Loebe M, Mehra MR, Sulemanjee NZ, Thohan V, Trachtenberg BH, Uriel N, Volk RJ, Estep JD, Blumenthal-Barby JS
BMC medical informatics and decision making
A principal components analysis of factors associated with successful implementation of an LVAD decision support tool. BMC Med Inform Decis Mak. 2021 03 20; 21(1):106.
A principal components analysis of factors associated with successful implementation of an LVAD decision support tool.
Pagani FD, Mehra MR, Cowger JA, Horstmanshof DA, Silvestry SC, Atluri P, Cleveland JC, Lindenfeld J, Roberts GJ, Bharmi R, Dalal N, Kormos RL, Rogers JG
Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study. J Heart Lung Transplant. 2021 05; 40(5):323-333.
Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study.
Machine learning, artificial intelligence and mechanical circulatory support: A primer for clinicians. J Heart Lung Transplant. 2021 06; 40(6):414-425.
Machine learning, artificial intelligence and mechanical circulatory support: A primer for clinicians.
Il'Giovine ZJ, Williams JB, Mason RP, Sherratt SCR, Hsich EM, Lever H, Mehra MR, Starling RC
Kinetics of generic tacrolimus in heart transplantation: A cautionary note. J Heart Lung Transplant. 2021 07; 40(7):569-572.
Kinetics of generic tacrolimus in heart transplantation: A cautionary note.
Khan MS, Kumar P, Sreenivasan J, Khan SU, Nasir K, Mehra MR, O' Donnell C, Warraich HJ
Circulation. Cardiovascular quality and outcomes
Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States. Circ Cardiovasc Qual Outcomes. 2021 04; 14(4):e007341.
Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States.
Mehra MR, Cleveland JC, Uriel N, Cowger JA, Hall S, Horstmanshof D, Naka Y, Salerno CT, Chuang J, Williams C, Goldstein DJ
Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021 08; 23(8):1392-1400.
Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
Seferovic PM, Tsutsui H, McNamara DM, Ristic AD, Basso C, Bozkurt B, Cooper LT, Filippatos G, Ide T, Inomata T, Klingel K, Linhart A, Lyon AR, Mehra MR, Polovina M, Milinkovic I, Nakamura K, Anker SD, Veljic I, Ohtani T, Okumura T, Thum T, Tschöpe C, Rosano G, Coats AJS, Starling RC
Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail. 2021 06; 23(6):854-871.
Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy.
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy. J Card Fail. 2021 07; 27(7):727-743.
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy.
Mehra MR, Crandall DL, Gustafsson F, Jorde UP, Katz JN, Netuka I, Uriel N, Connors JM, Sood P, Heatley G, Pagani FD
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial. Eur J Heart Fail. 2021 07; 23(7):1226-1237.
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
COVID-19 vaccination immune paresis in heart and lung transplantation. J Heart Lung Transplant. 2021 08; 40(8):763-766.
COVID-19 vaccination immune paresis in heart and lung transplantation.
Ferreira JP, Cleland JG, Lam CSP, Anker SD, Mehra MR, van Veldhuisen DJ, Byra WM, LaPolice DA, Greenberg B, Zannad F
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial. Clin Res Cardiol. 2022 Jan; 111(1):50-59.
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial.
Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. J Card Fail. 2021 11; 27(11):1291-1294.
Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure.
Bridging the palliative care chasm in advanced heart failure. Int J Cardiol. 2021 09 01; 338:147-149.
Bridging the palliative care chasm in advanced heart failure.
Bergmark BA, Zelniker TA, Kim M, Mehra MR, Stewart GC, Page DS, Woodcome EL, Givertz MM
Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation. Clin Transplant. 2021 10; 35(10):e14424.
Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation.
Cuddy S, Payne DL, Murphy DJ, Dunne RM, Bueno R, Blankstein R, Di Carli M, Mehra MR, Nohria A, Groarke JD
Incidental Coronary Artery Calcification in Cancer Imaging. JACC CardioOncol. 2019 Sep; 1(1):135-137.
Incidental Coronary Artery Calcification in Cancer Imaging.
Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, Krim SR, Maisel A, Mehra MR, Paul S, Sears SF, Sauer AJ, Smart F, Zughaib M, Castaneda P, Kelly J, Johnson N, Sood P, Ginn G, Henderson J, Adamson PB, Costanzo MR
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021 09 11; 398(10304):991-1001.
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
Confluence of the Physical Brain and Perceptual Mind With Ventricular Assist Devices. JACC Heart Fail. 2021 11; 9(11):852-854.
Confluence of the Physical Brain and Perceptual Mind With Ventricular Assist Devices.
Sheikh FH, Ravichandran AK, Goldstein DJ, Agarwal R, Ransom J, Bansal A, Kim G, Cleveland JC, Uriel N, Sheridan BC, Chomsky D, Patel SR, Dirckx N, Franke A, Mehra MR
Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial. Circ Heart Fail. 2021 10; 14(10):e008360.
Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
Coll MD, Yanamandala M, Ferro EG, Nutt CT, Wei EQ, Wang CJ, Mehra MR
Early Immunosuppression and Rapid Recovery of Cardiogenic Shock in Multisystem Inflammatory Syndrome From Convalescent COVID-19. JACC Case Rep. 2021 Sep 15; 3(12):1403-1408.
Early Immunosuppression and Rapid Recovery of Cardiogenic Shock in Multisystem Inflammatory Syndrome From Convalescent COVID-19.
Gong J, Castro RRT, Caron JP, Bay CP, Hainer J, Opotowsky AR, Mehra MR, Maron BA, Di Carli MF, Groarke JD, Nohria A
Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrum. ESC Heart Fail. 2022 02; 9(1):293-302.
Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrum.
Lim HS, Shaw S, Carter AW, Jayawardana S, Mossialos E, Mehra MR
A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective. J Heart Lung Transplant. 2022 02; 41(2):174-186.
A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
Cardiac Xenotransplantation: Rebirth Amidst an Uncertain Future. J Card Fail. 2022 05; 28(5):873-874.
Cardiac Xenotransplantation: Rebirth Amidst an Uncertain Future.
Zile MR, Desai AS, Costanzo MR, Ducharme A, Maisel A, Mehra MR, Paul S, Sears SF, Smart F, Chien C, Guha A, Guichard JL, Hall S, Jonsson O, Johnson N, Sood P, Henderson J, Adamson PB, Lindenfeld J
The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic. Eur Heart J. 2022 07 14; 43(27):2603-2618.
The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic.
Kanwar MK, Pagani FD, Mehra MR, Estep JD, Pinney SP, Silvestry SC, Uriel N, Goldstein DJ, Long J, Cleveland JC, Kormos RL, Wang A, Chuang J, Cowger JA
Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. J Card Fail. 2022 07; 28(7):1158-1168.
Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial.
Molina EJ, Cowger J, Lee S, Horstmanshof D, Cleveland JC, Goldstein DJ, Mehra MR, Uriel N, Salerno CT, Bourque K, Chuang J, Naka Y
Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2022 12; 114(6):2262-2269.
Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation.
Crespo-Leiro MG, Costanzo MR, Gustafsson F, Khush KK, Macdonald PS, Potena L, Stehlik J, Zuckermann A, Mehra MR
Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies. Eur Heart J. 2022 06 14; 43(23):2237-2246.
Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies.
Girerd N, Cleland J, Anker SD, Byra W, Lam CSP, Lapolice D, Mehra MR, van Veldhuisen DJ, Bresso E, Lamiral Z, Greenberg B, Zannad F
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction. Sci Rep. 2022 05 20; 12(1):8574.
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction.
Lavie CJ, daSilva-deAbreu A, Ventura HO, Mehra MR
Is There an Obesity Paradox in Cardiogenic Shock? J Am Heart Assoc. 2022 06 07; 11(11):e026088.
Is There an Obesity Paradox in Cardiogenic Shock?
Vidula H, Takeda K, Estep JD, Silvestry SC, Milano C, Cleveland JC, Goldstein DJ, Uriel N, Kormos RL, Dirckx N, Mehra MR
Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. JACC Heart Fail. 2022 07; 10(7):470-481.
Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
John R, Kanwar MK, Cleveland JC, Uriel N, Naka Y, Salerno C, Horstmanshof D, Hall SA, Cowger JA, Heatley G, Somo SI, Mehra MR
The Journal of thoracic and cardiovascular surgery
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. J Thorac Cardiovasc Surg. 2023 12; 166(6):1684-1694.e18.
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
Global challenges in left ventricular assist device therapy: a tale across two continents. Eur J Heart Fail. 2022 07; 24(7):1316-1318.
Global challenges in left ventricular assist device therapy: a tale across two continents.
Sadeh B, Ugolini S, Pinzon OW, Potapov EV, Selzman CH, Bader F, Zuckermann AO, Gomez-Mesa JE, Shah KS, Alharethi R, Morejon-Barragan P, Hanff T, Goldraich LA, Farrero M, MacDonald PS, Drakos S, Mehra MR, Stehlik J
Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey. Clin Transplant. 2022 07; 36(7):e14733.
Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey.
Bernier TD, Stern G, Buckley LF, Vieira JL, Siddiqi HK, Mehra MR
ASAIO journal (American Society for Artificial Internal Organs : 1992)
Intravenous Iron Repletion in Patients With Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2023 03 01; 69(3):e115-e117.
Intravenous Iron Repletion in Patients With Continuous-Flow Left Ventricular Assist Devices.
Mehra MR, Boulet J, Pelletier-Galarneau M
The Panvascular Interplay in Pathophysiology and Prognosis of Cardiac Allograft Vasculopathy. J Am Coll Cardiol. 2022 10 25; 80(17):1629-1632.
The Panvascular Interplay in Pathophysiology and Prognosis of Cardiac Allograft Vasculopathy.
Hemodynamic Aberrancies in Left Ventricular Assist Device-Associated Heart Failure Syndromes. J Card Fail. 2022 12; 28(12):1738-1740.
Hemodynamic Aberrancies in Left Ventricular Assist Device-Associated Heart Failure Syndromes.
Cardiac Xenotransplantation: Challenges, Evolution, and Advances. JACC Basic Transl Sci. 2022 Jul; 7(7):716-729.
Cardiac Xenotransplantation: Challenges, Evolution, and Advances.
Mehra MR, Goldstein DJ, Cleveland JC, Cowger JA, Hall S, Salerno CT, Naka Y, Horstmanshof D, Chuang J, Wang A, Uriel N
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 09 27; 328(12):1233-1242.
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
Uriel N, Milano C, Agarwal R, Lee S, Cleveland J, Goldstein D, Wang A, Crandall D, Mehra MR
Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis. Eur J Heart Fail. 2023 02; 25(2):286-294.
Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
Mehra MR, Nayak A, Morris AA, Lanfear DE, Nemeh H, Desai S, Bansal A, Guerrero-Miranda C, Hall S, Cleveland JC, Goldstein DJ, Uriel N, Chen L, Bailey S, Anyanwu A, Heatley G, Chuang J, Estep JD
Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device. JACC Heart Fail. 2022 12; 10(12):948-959.
Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device.
Zile MR, Mehra MR, Ducharme A, Sears SF, Desai AS, Maisel A, Paul S, Smart F, Grafton G, Kumar S, Nossuli TO, Johnson N, Henderson J, Adamson PB, Costanzo MR, Lindenfeld J
Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial. JACC Heart Fail. 2022 12; 10(12):931-944.
Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial.
Artificial intelligence in cardiovascular disease: Challenges and benefits in developing nations. Prog Cardiovasc Dis. 2022 Sep-Oct; 74:129-130.
Artificial intelligence in cardiovascular disease: Challenges and benefits in developing nations.
Wert L, Stewart GC, Mehra MR, Milwidsky A, Jorde UP, Goldstein DJ, Selzman CH, Stehlik J, Alshamdin FD, Khaliel FH, Gustafsson F, Boschi S, Loforte A, Ajello S, Scandroglio AM, Tucanová Z, Netuka I, Schlöglhofer T, Zimpfer D, Zijderhand CF, Caliskan K, Dogan G, Schmitto JD, Maier S, Schibilsky D, Jawad K, Saeed D, Faerber G, Morshuis M, Hanuna M, Müller CS, Mulzer J, Kempfert J, Falk V, Potapov EV
A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device. J Thorac Cardiovasc Surg. 2024 04; 167(4):1322-1330.e6.
A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
Woolley AE, Gandhi AR, Jones ML, Kim JJ, Mallidi HR, Givertz MM, Baden LR, Mehra MR, Neilan AAM
The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients. Transplantation. 2023 04 01; 107(4):961-969.
The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients.
Gustafsson F, Damman K, Nalbantgil S, Van Laake LW, Tops LF, Thum T, Adamopoulos S, Bonios M, Coats AJ, Crespo-Leiro MG, Mehra MR, Filippatos G, Hill L, Metra M, Jankowska E, de Jonge N, Kaye D, Masetti M, Parissis J, Milicic D, Seferovic P, Rosano G, Ben Gal T
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023 04; 25(4):457-468.
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology.
Ostrominski JW, Machado SR, Mossialos E, Mehra MR, Vaduganathan M
Donor Diabetes Mellitus Status and Contemporary Outcomes After Cardiac Transplantation. JACC Heart Fail. 2023 04; 11(4):483-486.
Donor Diabetes Mellitus Status and Contemporary Outcomes After Cardiac Transplantation.
Schroder JN, Patel CB, DeVore AD, Bryner BS, Casalinova S, Shah A, Smith JW, Fiedler AG, Daneshmand M, Silvestry S, Geirsson A, Pretorius V, Joyce DL, Um JY, Esmailian F, Takeda K, Mudy K, Shudo Y, Salerno CT, Pham SM, Goldstein DJ, Philpott J, Dunning J, Lozonschi L, Couper GS, Mallidi HR, Givertz MM, Pham DT, Shaffer AW, Kai M, Quader MA, Absi T, Attia TS, Shukrallah B, Sun BC, Farr M, Mehra MR, Madsen JC, Milano CA, D'Alessandro DA
Transplantation Outcomes with Donor Hearts after Circulatory Death. N Engl J Med. 2023 06 08; 388(23):2121-2131.
Transplantation Outcomes with Donor Hearts after Circulatory Death.
Desai AS, Maisel A, Mehra MR, Zile MR, Ducharme A, Paul S, Sears SF, Smart F, Bhatt K, Krim S, Henderson J, Johnson N, Adamson PB, Costanzo MR, Lindenfeld J
Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides. JACC Heart Fail. 2023 06; 11(6):691-698.
Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides.
Manla Y, Badarin FA, Bader N, Lee-St John T, Mehra MR, Bader F
Worldwide and Country-Specific Impact of the COVID-19 Pandemic on Heart Transplantation Volumes: A Longitudinal Analysis of 2020 and 2021. Curr Probl Cardiol. 2023 Nov; 48(11):101870.
Worldwide and Country-Specific Impact of the COVID-19 Pandemic on Heart Transplantation Volumes: A Longitudinal Analysis of 2020 and 2021.
Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions. JACC Basic Transl Sci. 2023 Jun; 8(6):720-727.
Fallacies of Using the Win Ratio in Cardiovascular Trials: Challenges and Solutions.
Mechanical circulatory support for adults in Japan: A 10-year perspective. Artif Organs. 2023 Jun; 47(6):914-924.
Mechanical circulatory support for adults in Japan: A 10-year perspective.
Angiotensin-Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: You Win Some, You Lose Some. J Am Coll Cardiol. 2023 07 04; 82(1):13-15.
Angiotensin-Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: You Win Some, You Lose Some.
Lena A, Wilkenshoff U, Hadzibegovic S, Porthun J, Rösnick L, Fröhlich AK, Zeller T, Karakas M, Keller U, Ahn J, Bullinger L, Riess H, Rosen SD, Lyon AR, Lüscher TF, Totzeck M, Rassaf T, Burkhoff D, Mehra MR, Bax JJ, Butler J, Edelmann F, Haverkamp W, Anker SD, Packer M, Coats AJS, von Haehling S, Landmesser U, Anker MS
Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer. J Am Coll Cardiol. 2023 04 25; 81(16):1569-1586.
Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.
Saeed D, Feldman D, Banayosy AE, Birks E, Blume E, Cowger J, Hayward C, Jorde U, Kremer J, MacGowan G, Maltais S, Maybaum S, Mehra M, Shah KB, Mohacsi P, Schweiger M, Schroeder SE, Shah P, Slepian M, Tops LF, Alvarez P, Arabia F, Aslam S, Benson-Louis L, Birati E, Buchholz HW, Cedars A, Christensen D, Ciarka A, Coglianese E, Cogswell R, Cook J, Copeland J, Costello JG, Drakos SG, Eghtesady P, Elliot T, Estep JD, Eulert-Grehn JJ, Fabrizio R, Garbade J, Gelow J, Guglin M, Hernandez-Montfort J, Horstmanshof D, John R, Kanwar M, Khaliel F, Kim G, Kumar S, Lavee J, Leache M, Leprince P, Lim S, Loforte A, Maly J, Najjar S, Netuka I, Pamboukian SV, Patel SR, Pinney S, Pluym CV, Potapov E, Robson D, Rochlani Y, Russell S, Sandau K, Sandoval E, Sayer G, Schettle S, Schibilsky D, Schlöglhofer T, Schmitto J, Siddique A, Silvestry S, Slaughter MS, Sun B, Takayama H, Tedford R, Teuteberg JJ, Ton VK, Uriel N, Vierecke J, Zimpfer D, D'Alessandro D
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update. J Heart Lung Transplant. 2023 07; 42(7):e1-e222.
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update.
Life-Prolonging Benefits of LVAD Therapy in Advanced Heart Failure: A Clinician's Action and Communication Aid. JACC Heart Fail. 2023 08; 11(8 Pt 1):1011-1017.
Life-Prolonging Benefits of LVAD Therapy in Advanced Heart Failure: A Clinician's Action and Communication Aid.
Nayak A, Hall SA, Uriel N, Goldstein DJ, Cleveland JC, Cowger JA, Salerno CT, Naka Y, Horstmanshof D, Crandall D, Wang A, Mehra MR
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device. J Am Coll Cardiol. 2023 08 29; 82(9):771-781.
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
Sharma A, Caldeira D, Razaghizad A, Pinto FJ, van Veldhuisen DJ, Mehra MR, Lam CSP, Cleland J, Anker SD, Greenberg B, Ferreira JP, Zannad F
Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF. BMJ Open. 2023 08 11; 13(8):e068865.
Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF.
Boulet J, Kelleher J, Wanderley MRB, Nohria A, Andersson C, Kim M, Mehra MR
Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation. Prog Cardiovasc Dis. 2023 Nov-Dec; 81:48-53.
Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation.
Ramu B, Cogswell R, Ravichandran AK, Cleveland J, Mehra MR, Goldstein D, Uriel N, Dirckx N, Ahmed S, Yuzefpolskaya M
Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men. JACC Heart Fail. 2023 12; 11(12):1692-1704.
Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men.
Overcoming vulnerability in heart failure: Transitional tactical toughness. Eur J Heart Fail. 2023 11; 25(11):2018-2020.
Overcoming vulnerability in heart failure: Transitional tactical toughness.
Singh MM, Bano T, Pagare D, Sharma N, Devi R, Mehra M
Knowledge and attitude towards tuberculosis in a slum community of Delhi. J Commun Dis. 2002 Sep; 34(3):203-14.
Knowledge and attitude towards tuberculosis in a slum community of Delhi.
Contemporary Left Ventricular Assist Device Therapy as a Bridge or Alternative to Transplantation. Transplantation. 2024 06 01; 108(6):1333-1341.
Contemporary Left Ventricular Assist Device Therapy as a Bridge or Alternative to Transplantation.
Singh M, Teodorescu DL, Rowlett M, Wang SX, Balcells M, Park C, Bernardo B, McGarel S, Reeves C, Mehra MR, Zhao X, Yuk H, Roche ET
Advanced materials (Deerfield Beach, Fla.)
A Tunable Soft Silicone Bioadhesive for Secure Anchoring of Diverse Medical Devices to Wet Biological Tissue. Adv Mater. 2024 Jan; 36(3):e2307288.
A Tunable Soft Silicone Bioadhesive for Secure Anchoring of Diverse Medical Devices to Wet Biological Tissue.
Awareness about pulse polio immunization among the general population in Delhi. Indian J Med Sci. 2001 Aug; 55(8):453-7.
Awareness about pulse polio immunization among the general population in Delhi.
Crossing the chasm of donor organ recovery in heart transplantation. Eur Heart J. 2023 11 21; 44(44):4675-4677.
Crossing the chasm of donor organ recovery in heart transplantation.
Zile MR, Kahwash R, Sarkar S, Koehler J, Zielinski T, Mehra MR, Fonarow GC, Gulati S, Butler J
A Novel Heart Failure Diagnostic Risk Score Using a Minimally Invasive Subcutaneous Insertable Cardiac Monitor. JACC Heart Fail. 2024 01; 12(1):182-196.
A Novel Heart Failure Diagnostic Risk Score Using a Minimally Invasive Subcutaneous Insertable Cardiac Monitor.
Mehra MR, Netuka I, Uriel N, Katz JN, Pagani FD, Jorde UP, Gustafsson F, Connors JM, Ivak P, Cowger J, Ransom J, Bansal A, Takeda K, Agarwal R, Byku M, Givertz MM, Bitar A, Hall S, Zimpfer D, Vega JD, Kanwar MK, Saeed O, Goldstein DJ, Cogswell R, Sheikh FH, Danter M, Pya Y, Phancao A, Henderson J, Crandall DL, Sundareswaran K, Soltesz E, Estep JD
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial. JAMA. 2023 12 12; 330(22):2171-2181.
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
The transformative potential of left ventricular assist devices in advanced heart failure: no more a therapeutic orphan. Eur Heart J. 2024 Feb 21; 45(8):626-628.
The transformative potential of left ventricular assist devices in advanced heart failure: no more a therapeutic orphan.
Grewal J, Tripathi N, Bortner B, Gregoski MJ, Cook D, Britt A, Hajj J, Rofael M, Sheidu M, Montovano MJ, Mehta M, Hajduczok AG, Rajapreyar IN, Brailovsky Y, Genuardi MV, Kanwar MK, Atluri P, Lander M, Shah P, Hsu S, Kilic A, Houston BA, Mehra MR, Sheikh FH, Tedford RJ
A multicenter evaluation of the HeartMate 3 risk score. J Heart Lung Transplant. 2024 04; 43(4):626-632.
A multicenter evaluation of the HeartMate 3 risk score.
Monzo L, Girerd N, Ferreira JP, Lamiral Z, Anker SD, Cleland JGF, Kondo T, McMurray JJV, Lam CSP, Mehra MR, Veldhuisen DJV, Greenberg B, Zannad F
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial. J Card Fail. 2024 04; 30(4):618-623.
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial.
Kostick-Quenet KM, Lang B, Dorfman N, Estep J, Mehra MR, Bhimaraj A, Civitello A, Jorde U, Trachtenberg B, Uriel N, Kaplan H, Gilmore-Szott E, Volk R, Kassi M, Blumenthal-Barby JS
Patients' and physicians' beliefs and attitudes towards integrating personalized risk estimates into patient education about left ventricular assist device therapy. Patient Educ Couns. 2024 May; 122:108157.
Patients' and physicians' beliefs and attitudes towards integrating personalized risk estimates into patient education about left ventricular assist device therapy.
Lindenfeld J, Costanzo MR, Zile MR, Ducharme A, Troughton R, Maisel A, Mehra MR, Paul S, Sears SF, Smart F, Johnson N, Henderson J, Adamson PB, Desai AS, Abraham WT
Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2024 02 13; 83(6):682-694.
Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction.
Gosev I, Pham DT, Um JY, Anyanwu AC, Itoh A, Kotkar K, Takeda K, Naka Y, Peltz M, Silvestry SC, Couper G, Leacche M, Rao V, Sun B, Tedford RJ, Mokadam N, McNutt R, Crandall D, Mehra MR, Salerno CT
Ventricular assist device using a thoracotomy-based implant technique: Multi-Center Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy (HM3 SWIFT). J Thorac Cardiovasc Surg. 2024 11; 168(5):1474-1484.e12.
Ventricular assist device using a thoracotomy-based implant technique: Multi-Center Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy (HM3 SWIFT).
Sylvester KW, Grandoni J, Rhoten M, Coakley L, Lyons-Matiello E, Frankel K, Fortin B, Jolley K, Park HS, Freedman RY, Mehra MR, Givertz MM, Connors JM
Assessment of Temporary Warfarin Reversal in Patients With Left Ventricular Assist Devices: the KVAD Study. J Card Fail. 2024 09; 30(9):1111-1119.
Assessment of Temporary Warfarin Reversal in Patients With Left Ventricular Assist Devices: the KVAD Study.
Netuka I, Tucanova Z, Ivak P, Gregor S, Kolesar DM, Marek T, Melenovsky V, Binova J, Dorazilova Z, Hegarova M, Podolec M, Riha H, Connors JM, Mehra MR
A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study. Circulation. 2024 Aug 06; 150(6):509-511.
A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study.
Effectiveness of syndromic approach in management of reproductive tract infections in women. Indian J Med Sci. 2001 Apr; 55(4):209-14.
Effectiveness of syndromic approach in management of reproductive tract infections in women.
Gordon LB, Basso S, Maestranzi J, Aikawa E, Clift CL, Cammardella AG, Danesi TH, Del Nido PJ, Edelman ER, Hamdy A, Hegde SM, Kleinman ME, Maschietto N, Mehra MR, Mukundan S, Musumeci F, Russo M, Rybicki FJ, Shah PB, Suarez WA, Tuminelli K, Zaleski K, Prakash A, Gerhard-Herman M
Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome. Front Cardiovasc Med. 2024; 11:1356010.
Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome.
Direct Oral Anticoagulant Therapy With A Fully Magnetically Levitated LVAD and Bridging to Heart Transplantation: A DOT-HM3 Study Analysis. J Card Fail. 2024 Nov; 30(11):1512-1515.
Direct Oral Anticoagulant Therapy With A Fully Magnetically Levitated LVAD and Bridging to Heart Transplantation: A DOT-HM3 Study Analysis.
Adamopoulos S, Bonios M, Ben Gal T, Gustafsson F, Abdelhamid M, Adamo M, Bayes-Genis A, Böhm M, Chioncel O, Cohen-Solal A, Damman K, Di Nora C, Hashmani S, Hill L, Jaarsma T, Jankowska E, Lopatin Y, Masetti M, Mehra MR, Milicic D, Moura B, Mullens W, Nalbantgil S, Panagiotou C, Piepoli M, Rakisheva A, Ristic A, Rivinius R, Savarese G, Thum T, Tocchetti CG, Tops LF, Van Laake LW, Volterrani M, Seferovic P, Coats A, Metra M, Rosano G
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2024 Nov; 26(11):2304-2322.
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC.
Simitsis P, Nohria A, Kelleher J, Boulet J, Wanderley MRB, Natarajan P, Libby P, Mehra MR
Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation. J Card Fail. 2025 Feb; 31(2):400-410.
Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation.
The Clinical Conundrum of Vasoplegia With Mechanical Circulatory Support Devices. JACC Adv. 2024 May; 3(5):100914.
The Clinical Conundrum of Vasoplegia With Mechanical Circulatory Support Devices.
Shah P, Sayer G, Sinha SS, Kanwar MK, Cowger JA, Pagani FD, Nayak A, Mehra MR, Cleveland JC, Psotka MA, Singh R, Desai SS, Lu Q, Hu Y, Connolly A, Kormos RL, Uriel N
Dynamic Risk Estimation of Adverse Events in Ambulatory LVAD Patients: A MOMENTUM 3 Analysis. JACC Heart Fail. 2024 Nov; 12(11):1898-1912.
Dynamic Risk Estimation of Adverse Events in Ambulatory LVAD Patients: A MOMENTUM 3 Analysis.
Instructor in Psychology in the Department of Psychiatry
Jayawardana S, Campbell A, Aitken M, Andersson CE, Mehra MR, Mossialos E
Global consumption patterns of combination hypertension medication: An analysis of pharmaceutical sales data from 2010-2021. PLOS Glob Public Health. 2024; 4(9):e0003698.
Global consumption patterns of combination hypertension medication: An analysis of pharmaceutical sales data from 2010-2021.
Cikes M, Yuzefpolskaya M, Gustafsson F, Mehra MR
Antithrombotic Strategies With Left Ventricular Assist Devices. J Card Fail. 2024 11; 30(11):1489-1495.
Antithrombotic Strategies With Left Ventricular Assist Devices.
Advancing immunosuppression in heart transplantation: "one step forward, two steps back. Am J Transplant. 2013 May; 13(5):1119-20.
Advancing immunosuppression in heart transplantation: "one step forward, two steps back.
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events. Vasc Health Risk Manag. 2013; 9:245-54.
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events.
"Flexo-dyspnea": A novel clinical observation in the heart failure syndrome. J Heart Lung Transplant. 2013 Aug; 32(8):844-5.
"Flexo-dyspnea": A novel clinical observation in the heart failure syndrome.
A world view of heart failure requiring hospitalization. Foreword. Heart Fail Clin. 2013 Jul; 9(3):ix-x.
A world view of heart failure requiring hospitalization. Foreword.
Transplantation Outcomes in Hepatitis C Virus-Positive Donor Hearts After Circulatory Death. J Card Fail. 2025 Feb; 31(2):477-480.
Transplantation Outcomes in Hepatitis C Virus-Positive Donor Hearts After Circulatory Death.
Cherla A, Kyriopoulos I, Pearcy P, Tsangalidou Z, Hajrulahovic H, Theodorakis P, Andersson CE, Mehra MR, Mossialos E
Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995-2020: a retrospective secondary data analysis. Lancet Reg Health Eur. 2024 Dec; 47:101079.
Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995-2020: a retrospective secondary data analysis.
Nordan T, Keshk M, Hackmann A, Givertz MM, Mehra MR, Cunningham MJ, Itoh A
The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device. J Thorac Cardiovasc Surg. 2025 06; 169(6):1772-1781.e5.
The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device.
The persistent poor prognosis in cardiogenic shock: Insights from recent trials. Eur J Heart Fail. 2025 Jan; 27(1):37-39.
The persistent poor prognosis in cardiogenic shock: Insights from recent trials.
Shah P, Cowger JA, Mehra MR, Lu Q, Uriel N
Reply: Enhancing Dynamic Risk Prediction in LVAD Patients: Methodological Considerations. JACC Heart Fail. 2024 Nov; 12(11):1953.
Reply: Enhancing Dynamic Risk Prediction in LVAD Patients: Methodological Considerations.
Lavie CJ, Tutor AW, Mehra MR, O'Connor CM
Omega-3 Fish Oils in Prevention and Management of Heart Failure. Mayo Clin Proc. 2024 Dec; 99(12):1857-1859.
Omega-3 Fish Oils in Prevention and Management of Heart Failure.
Monzo L, Bresso E, Dickstein K, Pitt B, Cleland JGF, Anker SD, Lam CSP, Mehra MR, van Veldhuisen DJ, Greenberg B, Zannad F, Girerd N
Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction. Eur J Heart Fail. 2025 Dec; 27(12):3378-3391.
Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction.
Molina EJ, Ahmed MM, Sheikh FH, Cleveland JC, Goldstein DJ, Uriel NY, Wang A, Revis JJ, Mehra MR
Left Ventricular Dimensions and Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device. JACC Heart Fail. 2025 May; 13(5):798-811.
Left Ventricular Dimensions and Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device.
Gustafsson F, Uriel N, Netuka I, Katz JN, Pagani FD, Connors JM, Jorde UP, Zimpfer D, Pya Y, Conway J, Anyanwu A, Scandroglio AM, Sulemanjee N, Atluri P, Keebler M, Selzman CH, Alexis JD, Hayward C, Henderson J, Dirckx N, Gazzola C, Mehra MR
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial. JAMA Cardiol. 2025 03 01; 10(3):235-242.
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial.
"Surveillance without scars": The quest for noninvasive detection of cardiac allograft rejection. J Heart Lung Transplant. 2025 Apr; 44(4):570-572.
"Surveillance without scars": The quest for noninvasive detection of cardiac allograft rejection.
Sayer G, Ahmed MM, Mehra MR, Gosev I, Vidula H, Devore AD, Horstmanshof DA, Cleveland JC, Stewart GC, Slaughter MS, Mudy K, Wang A, Uriel N
Implantable Cardioverter-Defibrillators and Cardiovascular Resynchronization Therapy with Left Ventricular Assist DevicesA MOMENTUM 3 Trial Analysis. J Card Fail. 2025 10; 31(10):1548-1557.
Implantable Cardioverter-Defibrillators and Cardiovascular Resynchronization Therapy with Left Ventricular Assist DevicesA MOMENTUM 3 Trial Analysis.
Zimmerman GA, McIntyre TM, Mehra M, Prescott SM
Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol. 1990 Feb; 110(2):529-40.
Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.
Stehlik J, Hosenpud JD, Edwards LB, Hertz MI, Mehra MR
ISHLT International Registry for Heart and Lung Transplantation--into the fourth decade, from strength to strength. J Heart Lung Transplant. 2013 Oct; 32(10):941-50.
ISHLT International Registry for Heart and Lung Transplantation--into the fourth decade, from strength to strength.
Atrial fibrillation and heart failure: it takes two to tango. Foreword. Heart Fail Clin. 2013 Oct; 9(4):xiii-xiv.
Atrial fibrillation and heart failure: it takes two to tango. Foreword.
Fat, cachexia, and the right ventricle in heart failure: a web of complicity. J Am Coll Cardiol. 2013 Oct 29; 62(18):1671-1673.
Fat, cachexia, and the right ventricle in heart failure: a web of complicity.
Cardio-systemic Stress and Trained Innate Immune Memory in Heart Failure. Transplantation. 2025 Apr 01; 109(4):565-568.
Cardio-systemic Stress and Trained Innate Immune Memory in Heart Failure.
Decoding cardiac allograft vasculopathy: Harnessing multimodal imaging to improve prognosis. J Heart Lung Transplant. 2025 Jun; 44(6):913-915.
Decoding cardiac allograft vasculopathy: Harnessing multimodal imaging to improve prognosis.
Khaliel FH, Haq MI, Alsulbud AK, Altwaijri YA, Alenazy AB, Almustafa AR, Aly AA, Mehra MR
"First-in-human" totally robotic orthotopic heart transplant. J Heart Lung Transplant. 2025 Jun; 44(6):1000-1003.
"First-in-human" totally robotic orthotopic heart transplant.
The Emerging Myth of Primary Graft Dysfunction in the Era of Advanced Organ Preservation in Heart Transplantation. J Card Fail. 2025 Jun; 31(6):979-982.
The Emerging Myth of Primary Graft Dysfunction in the Era of Advanced Organ Preservation in Heart Transplantation.
Durable mechanical circulatory support in advanced heart failure: a critical care cardiology perspective. Cardiol Clin. 2013 Nov; 31(4):581-93, viii-ix.
Durable mechanical circulatory support in advanced heart failure: a critical care cardiology perspective.
Gheorghiade M, Vaduganathan M, Fonarow GC, Greene SJ, Greenberg BH, Liu PP, Massie BM, Mehra MR, Metra M, Zannad F, Cleland JG, van Veldhuisen DJ, Shah AN, Butler J
Anticoagulation in heart failure: current status and future direction. Heart Fail Rev. 2013 Nov; 18(6):797-813.
Anticoagulation in heart failure: current status and future direction.
Berry GJ, Burke MM, Andersen C, Bruneval P, Fedrigo M, Fishbein MC, Goddard M, Hammond EH, Leone O, Marboe C, Miller D, Neil D, Rassl D, Revelo MP, Rice A, Rene Rodriguez E, Stewart S, Tan CD, Winters GL, West L, Mehra MR, Angelini A
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2013 Dec; 32(12):1147-62.
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.
A history of devices as an alternative to heart transplantation. Heart Fail Clin. 2014 Jan; 10(1 Suppl):S1-12.
A history of devices as an alternative to heart transplantation.
Adults with congenital heart disease: growing pains. Heart Fail Clin. 2014 Jan; 10(1):xiii-xiv.
Adults with congenital heart disease: growing pains.
Stehlik J, Farr MA, Mehra MR, Schroder JN, D'Alessandro DA, Pal JD, Villavicencio MA, Gruber PJ, Couper GS, Shudo Y, Patel PC, Daneshmand MA, Klein L, Shah AS, Skipper ER, Esmailian F, Goldstein D, Ohira S, Lozonschi L, Kaczorowski DJ, Takeda K, Malyala RSR, Haft JW, Meyer DM, Sun BC, Pretorius V, Kilic A, Anyanwu AC, Williams CT, Pham DT, Kai M, Sulemanjee NZ, Itoh A, Funamoto M, Salerno CT, Ikonomidis JS, Durham LA, Shaffer A, Zhou X, Zafar F, Pinney SP, Milano CA
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry. Circulation. 2025 Apr; 151(13):896-909.
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry.
Advancing antithrombotic therapies for left ventricular assist devices: challenges, innovations, and future perspectives. Future Cardiol. 2025 Jun; 21(7):411-413.
Advancing antithrombotic therapies for left ventricular assist devices: challenges, innovations, and future perspectives.
Reply: Small Left Ventricular Cavity Size and Big Risks for Females on Durable LVAD Support. JACC Heart Fail. 2025 May; 13(5):885.
Reply: Small Left Ventricular Cavity Size and Big Risks for Females on Durable LVAD Support.
Kalra PR, Gogorishvili I, Khabeishvili G, Málek F, Toman O, Critoph C, Flett AS, Cowburn PJ, Mehra MR, Sheridan WS, Britton JR, Buxo T, Kealy RM, Kent A, Greene BR, Guha K, Gardner RS, Loke I, Vazir A, Brugts JJ, Gray A, Testani JM, Damman K
First-in-Human Implantable Inferior Vena Cava Sensor for Remote Care in Heart Failure: FUTURE-HF. JACC Heart Fail. 2025 Jun; 13(6):1000-1010.
First-in-Human Implantable Inferior Vena Cava Sensor for Remote Care in Heart Failure: FUTURE-HF.
Pagani FD, Netuka I, Jorde UP, Katz JN, Gustafsson F, Connors JM, Uriel N, Soltesz EG, Ivak P, Bansal A, Bitar A, Vega JD, Goldstein D, Danter M, Pya Y, Ravichandran A, Conway J, Adler ED, Chung ES, Grinstein J, Dirckx N, Iravani B, Mehra MR
Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy. JACC Heart Fail. 2025 Jul; 13(7):102411.
Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy.
DanGerous Extrapolations Within and Beyond STEMI Cardiogenic Shock. JACC Heart Fail. 2025 Dec; 13(12):102474.
DanGerous Extrapolations Within and Beyond STEMI Cardiogenic Shock.
Zile MR, Abraham WT, Stevenson LW, Costanzo MR, Angermann CE, Mehra MR, Desai AS, Ducharme A, Johnson N, Henderson J, Lindenfeld J
Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and All-Cause Mortality in Patients With Chronic Heart Failure. Circ Heart Fail. 2025 Jun; 18(6):e012754.
Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and All-Cause Mortality in Patients With Chronic Heart Failure.
Wilcox JE, Fonarow GC, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Circ Heart Fail. 2014 Jan; 7(1):146-53.
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
Continuous flow left ventricular assist device related aortic root thrombosis complicated by left main coronary artery occlusion. J Heart Lung Transplant. 2014 Jan; 33(1):119-20.
Continuous flow left ventricular assist device related aortic root thrombosis complicated by left main coronary artery occlusion.
The vexing problem of thrombosis in long-term mechanical circulatory support. J Heart Lung Transplant. 2014 Jan; 33(1):1-11.
The vexing problem of thrombosis in long-term mechanical circulatory support.
Tadokoro N, Cho M, Nordan T, Hackmann AE, Takemoto S, Givertz MM, Dey T, Mehra MR, Itoh A
Impact of delayed kidney graft function on long-term outcomes in simultaneous heart-kidney transplantation. J Heart Lung Transplant. 2026 Feb; 45(2):215-224.
Impact of delayed kidney graft function on long-term outcomes in simultaneous heart-kidney transplantation.
Tadokoro N, Takemoto S, Cho M, Nordan T, Givertz MM, Dey T, Mehra MR, Itoh A
Outcomes of simultaneous heart-kidney transplantation using donation after circulatory death donors: A propensity-matched analysis from the UNOS registry. J Heart Lung Transplant. 2026 Feb; 45(2):204-211.
Outcomes of simultaneous heart-kidney transplantation using donation after circulatory death donors: A propensity-matched analysis from the UNOS registry.
Mehra MR, Park MH, Landzberg MJ, Lala A, Waxman AB
Right heart failure: toward a common language. J Heart Lung Transplant. 2014 Feb; 33(2):123-6.
Right heart failure: toward a common language.
Long-term immunosuppression and malignancy in thoracic transplantation: where is the balance? J Heart Lung Transplant. 2014 May; 33(5):461-7.
Long-term immunosuppression and malignancy in thoracic transplantation: where is the balance?
Comorbid conditions in heart failure: an unhappy marriage. Heart Fail Clin. 2014 Apr; 10(2):ix.
Comorbid conditions in heart failure: an unhappy marriage.
Emergent use of mechanical circulatory support devices: ethical dilemmas. Curr Opin Cardiol. 2014 May; 29(3):281-4.
Emergent use of mechanical circulatory support devices: ethical dilemmas.
Shah KB, Kwakkel-van Erp JM, Migliore C, Orr Y, Corris PA, Glanville AR, Slaughter MS, West LJ, Mehra MR
Scientific progress in heart and lung failure, mechanical circulatory support, and transplantation: highlights from the Journal of Heart and Lung Transplantation. J Heart Lung Transplant. 2014 Mar; 33(3):223-8.
Scientific progress in heart and lung failure, mechanical circulatory support, and transplantation: highlights from the Journal of Heart and Lung Transplantation.
Circulation journal : official journal of the Japanese Circulation Society
Challenges in long-term mechanical circulatory support and biological replacement of the failing heart. Circ J. 2014; 78(2):288-99.
Challenges in long-term mechanical circulatory support and biological replacement of the failing heart.
Gupta DK, Skali H, Rivero J, Campbell P, Griffin L, Smith C, Foster C, Claggett B, Glynn RJ, Couper G, Givertz MM, Mehra MR, Di Carli M, Solomon SD, Pfeffer MA
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device. J Heart Lung Transplant. 2014 Apr; 33(4):372-81.
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device.
Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013 Apr; 1(2):93-102.
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.
Lavie CJ, De Schutter A, Alpert MA, Mehra MR, Milani RV, Ventura HO
Obesity paradox, cachexia, frailty, and heart failure. Heart Fail Clin. 2014 Apr; 10(2):319-26.
Obesity paradox, cachexia, frailty, and heart failure.
Revista española de cardiología (English ed.)
Risk assessment in critically ill patients awaiting transplantation: a step forward. Rev Esp Cardiol (Engl Ed). 2011 Mar; 64(3):175-6.
Thin blood and thinner margins in anticoagulation with left ventricular assist devices: Living on the Razor's Edge. J Heart Lung Transplant. 2025 Aug; 44(8):1339-1342.
Thin blood and thinner margins in anticoagulation with left ventricular assist devices: Living on the Razor's Edge.
Cikes M, Planinc I, Brugts JJ, Claggett B, Jorde UP, Milicic D, Ruschitzka F, Uriel N, Jakus N, Loncaric F, Puskaric F, Rubis P, van Laake LW, Rudez I, Hegarova M, Mehra M, Solomon SD
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF). J Card Fail. 2026 Feb; 32(2):406-418.
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF).
The Creative Academic Leader: Six Attributes That Shape Discovery, Integrity, and Impact. J Card Fail. 2026 Feb; 32(2):515-518.
The Creative Academic Leader: Six Attributes That Shape Discovery, Integrity, and Impact.
Bekbossynova M, Andossova S, Jetybayeva-Gerchek S, Khissamutdinov N, Novikova S, Suigenbayev D, Vukicevic M, Mehra MR
The Kazakhstan Model for Heart Failure Care: A Nationally Integrated Approach to Advanced Cardiac Therapy. J Card Fail. 2026 Mar; 32(3):680-683.
The Kazakhstan Model for Heart Failure Care: A Nationally Integrated Approach to Advanced Cardiac Therapy.
Kanwar MK, Nayak A, Schlöglhofer T, Bernhardt AM, Hanff T, Muthiah K, Granegger M, Molina EJ, Uriel N, Netuka I, Mehra MR, Rogers J
The future of durable mechanical circulatory support devices: Emerging innovations. J Heart Lung Transplant. 2026 Jan 22.
The future of durable mechanical circulatory support devices: Emerging innovations.
Goldraich LA, Etges APBDS, Hastenteufel LCT, Lemos DM, Zuckermann A, Mehra MR, Polanczyk CA, Clausell N
The Cost of Medical Management in Advanced Heart Failure: A Latin American Perspective. Arq Bras Cardiol. 2025 Nov; 122(10):e20240813.
The Cost of Medical Management in Advanced Heart Failure: A Latin American Perspective.
Castagna F, Mehra MR, Nabzdyk CGS, Givertz MM
Vasoplegia Syndrome After Cardiac Surgery: Insights Into Mechanisms and Treatment. JACC Heart Fail. 2025 Jul; 13(7):102482.
Vasoplegia Syndrome After Cardiac Surgery: Insights Into Mechanisms and Treatment.
Cikes M, Brugts JJ, Claggett B, Jorde UP, Milicic D, Planinc I, Ruschitzka F, Uriel N, Kulac I, Jakus N, Loncaric F, Puskaric F, Sipus D, Gasparovic H, Rubis P, van Laake LW, Rudez I, Hegarova M, Sestan G, Wisniowska-Smialek S, Wierzbicki K, Mehra MR, Solomon SD
Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy: Primary Results of the ENVAD-HF Trial. JACC Heart Fail. 2025 Nov; 13(11):102657.
Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy: Primary Results of the ENVAD-HF Trial.
Phenotypes of Peril: The Hidden Burden of End-Organ Failure in Cardiogenic Shock. J Card Fail. 2025 Oct; 31(10):1523-1525.
Phenotypes of Peril: The Hidden Burden of End-Organ Failure in Cardiogenic Shock.
Beyond the Pump: Reframing Cardiogenic Shock in Heart Failure Through a Multisystem Mechanistic Lens. JACC Heart Fail. 2026 Jan; 14(1):102711.
Beyond the Pump: Reframing Cardiogenic Shock in Heart Failure Through a Multisystem Mechanistic Lens.
Jain N, Santo EC, Lehto HR, Schaefer KG, Manning KA, Landzberg MJ, Warraich HJ, Givertz MM, Mehra MR, Tulsky JA, Desai AS
Implementing HeartPal: Design and Early Results of a Specialized Care Delivery Model for Advancing Palliative Care in Advanced Heart Disease Populations. J Card Fail. 2025 Oct 06.
Implementing HeartPal: Design and Early Results of a Specialized Care Delivery Model for Advancing Palliative Care in Advanced Heart Disease Populations.
Digital Twins and Artificial Intelligence in Heart Failure: The Premise and the Promise. J Card Fail. 2026 Jan 10.
Digital Twins and Artificial Intelligence in Heart Failure: The Premise and the Promise.
Szarek M, Bhatt DL, Miller M, Brinton EA, Tardif JC, Ballantyne CM, Ketchum SB, Mehra MR, Steg PG
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT. Eur J Prev Cardiol. 2026 Jan 16.
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT.
Connors JM, Gustafsson F, Uriel N, Pagani FD, Jorde UP, Katz JN, Netuka I, Zimpfer D, Nemeh H, Ransom JM, Agarwal R, Byku M, Givertz MM, Hall S, Kanwar MK, Cogswell R, Sheikh FH, Phancao A, Ravichandran A, Conway J, Adler E, Chung ES, Grinstein J, Dirckx N, Chakouri N, Mehra MR
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial. Eur Heart J. 2026 Feb 23; 47(8):942-952.
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial.
Mehra MR, Mohiuddin MM, Reichart B, Abicht JM, Boulet J, Cooper DKC, Cowan PJ, Crespo-Leiro MG, Denner J, Fishman JA, Griffith BP, Hawthorne WJ, Joyce E, Konstantinov IE, Lala A, Langin M, Padera RF, Pierson Iii RN, Schnieke A, Scobie L, Uber PA, Wolf E, Woolley AE
The 2026 International Society for Heart and Lung Transplantation Consensus Statement on clinical cardiac xenotransplantation. J Heart Lung Transplant. 2026 Apr; 45(4):e129-e147.
The 2026 International Society for Heart and Lung Transplantation Consensus Statement on clinical cardiac xenotransplantation.
Isath A, Vukicevic M, Moayedifar R, Zuckermann A, Mehra MR
Evolving Paradigms and Future Frontiers in Heart Transplantation in the Modern Era: a State-of-Art Focus Review. J Card Fail. 2025 Aug 30.
Evolving Paradigms and Future Frontiers in Heart Transplantation in the Modern Era: a State-of-Art Focus Review.
Comment on Aspirin Avoidance in Patients With LVADs-Reply. JAMA Cardiol. 2025 Jul 23.
Comment on Aspirin Avoidance in Patients With LVADs-Reply.
Aliabadi-Zuckermann A, Zuckermann A, Mehra MR
"No Hearts Left Behind": A global proposal to rescue discarded donor hearts. J Heart Lung Transplant. 2025 Nov; 44(11):1833-1835.
"No Hearts Left Behind": A global proposal to rescue discarded donor hearts.
Oo MMS, Jayawardana S, Campbell A, Aitken M, Patel KV, Nasir K, Mehra M, Mossialos E
Trends in global glucose lowering medication consumption: Insights from pharmaceutical sales data (2010-2021). PLOS Glob Public Health. 2025; 5(10):e0005326.
Trends in global glucose lowering medication consumption: Insights from pharmaceutical sales data (2010-2021).
Fudim M, Mehra MR, Damman K, Uriel N, Kalra PR, Sweeney F, Carmody D, Tucker J, Greene BR, Testani JM
Derivation of a Personalized Congestion Score Using a Chronic Implantable Inferior Vena Cava Management System in Heart Failure: An Analysis from the FUTURE-HF Trial Portfolio. J Card Fail. 2025 Sep 28.
Derivation of a Personalized Congestion Score Using a Chronic Implantable Inferior Vena Cava Management System in Heart Failure: An Analysis from the FUTURE-HF Trial Portfolio.
Reply: From Small Cavities to Big Gains: Phosphodiesterase 5 Inhibitors in LVAD Care. JACC Heart Fail. 2026 Jan; 14(1):102757.
Reply: From Small Cavities to Big Gains: Phosphodiesterase 5 Inhibitors in LVAD Care.
Uriel N, Netuka I, Jorde UP, Pagani FD, Katz JN, Connors JM, Ivak P, Zimpfer D, Pya Y, Conway J, Gustafsson F, Nathan S, Scandroglio AM, Hayward C, D'Alessandro DA, Collins M, Dirckx N, Mehra MR
Impact of Atrial Fibrillation, Diabetes Mellitus, and Obesity on Outcomes With Aspirin Avoidance and Hemocompatibility With a Left Ventricular Assist Device: An Analysis From the ARIES-HM3 Trial. J Card Fail. 2025 Nov 26.
Impact of Atrial Fibrillation, Diabetes Mellitus, and Obesity on Outcomes With Aspirin Avoidance and Hemocompatibility With a Left Ventricular Assist Device: An Analysis From the ARIES-HM3 Trial.
Vukicevic M, Mehra MR, Padera RF, Isath A
Progressive Conduction System Disease in Hydroxychloroquine Cardiotoxicity: A Call for Early Vigilance. Am J Cardiol. 2026 Jan 15; 259:233-236.
Progressive Conduction System Disease in Hydroxychloroquine Cardiotoxicity: A Call for Early Vigilance.
Verma A, Habertheuer A, Prasad N, Hirji S, Givertz MM, Cunningham JW, Mehra MR, Itoh A
Journal of cardiovascular development and disease
Orthotopic Heart Transplantation with Concurrent Coronary Artery Bypass Grafting Using In Situ Internal Thoracic Artery. J Cardiovasc Dev Dis. 2026 Feb 13; 13(2).
Orthotopic Heart Transplantation with Concurrent Coronary Artery Bypass Grafting Using In Situ Internal Thoracic Artery.
Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Warner Stevenson L, Varosy PD, Welikovitch L
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm. 2014 Jul; 11(7):1271-303.
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014 Jul 01; 130(1):94-125.
Spilberg G, Carniato SL, King RM, van der Bom IM, Mehra M, Walvick RP, Wakhloo AK, Gounis MJ
AJNR. American journal of neuroradiology
Temporal evolution of susceptibility artifacts from coiled aneurysms on MR angiography: an in vivo canine study. AJNR Am J Neuroradiol. 2012 Apr; 33(4):655-60.
Temporal evolution of susceptibility artifacts from coiled aneurysms on MR angiography: an in vivo canine study.
Heart failure with preserved ejection fraction: a bouillabaisse. Heart Fail Clin. 2014 Jul; 10(3):xiii-xiv.
Heart failure with preserved ejection fraction: a bouillabaisse.
van der Bom IM, Mehra M, Walvick RP, Chueh JY, Gounis MJ
Quantitative evaluation of C-arm CT cerebral blood volume in a canine model of ischemic stroke. AJNR Am J Neuroradiol. 2012 Feb; 33(2):353-8.
Quantitative evaluation of C-arm CT cerebral blood volume in a canine model of ischemic stroke.
Right heart failure: toward a common language. Pulm Circ. 2013 Dec; 3(4):963-7.
Ziaeian B, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. J Am Coll Cardiol. 2014 Aug 26; 64(8):797-807.
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry.
Goldberg SW, Fisher SA, Wehman B, Mehra MR
Adults with congenital heart disease and heart transplantation: optimizing outcomes. J Heart Lung Transplant. 2014 Sep; 33(9):873-7.
Adults with congenital heart disease and heart transplantation: optimizing outcomes.
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014 Sep 16; 64(11):1143-77.
Pharmacotherapy for heart failure: the more we get to know, the more we need to know. Foreword. Heart Fail Clin. 2014 Oct; 10(4):ix-x.
Pharmacotherapy for heart failure: the more we get to know, the more we need to know. Foreword.
Stehlik J, Stevenson LW, Edwards LB, Crespo-Leiro MG, Delgado JF, Dorent R, Frigerio M, Macdonald P, MacGowan GA, Nanni Costa A, Rogers JG, Shah AS, Taylor R, Venkateswaran RV, Mehra MR
Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation. J Heart Lung Transplant. 2014 Oct; 33(10):975-84.
Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation.
Get a move on heart failure. Heart Fail Clin. 2015 Jan; 11(1):xiii.
Educational affairs at the International Society for Heart and Lung Transplantation: Perspective and governance of post-graduate learning dimensions. J Heart Lung Transplant. 2014 Nov; 33(11):1189-92.
Educational affairs at the International Society for Heart and Lung Transplantation: Perspective and governance of post-graduate learning dimensions.
Majmudar MD, Murthy VL, Shah RV, Kolli S, Mousavi N, Foster CR, Hainer J, Blankstein R, Dorbala S, Sitek A, Stevenson LW, Mehra MR, Di Carli MF
European heart journal. Cardiovascular Imaging
Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015 Aug; 16(8):900-9.
Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes.
Mehra M, Cossrow N, Kambili C, Underwood R, Makkar R, Potluri R
Assessment of tuberculosis burden in China using a dynamic disease simulation model. Int J Tuberc Lung Dis. 2013 Sep; 17(9):1186-94.
Assessment of tuberculosis burden in China using a dynamic disease simulation model.
Disease-modifying therapy and hospitalization risk in heart failure patients. Am J Manag Care. 2015 Jan; 21(1):39-47.
Disease-modifying therapy and hospitalization risk in heart failure patients.
The hi-tech age of heart failure management. Heart Fail Clin. 2015 Apr; 11(2):xi-xii.
The hi-tech age of heart failure management.
Zannad F, Greenberg B, Cleland JG, Gheorghiade M, van Veldhuisen DJ, Mehra MR, Anker SD, Byra WM, Fu M, Mills RM
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial. Eur J Heart Fail. 2015 Jul; 17(7):735-42.
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial.
Harinstein ME, Butler J, Greene SJ, Fonarow GC, Stockbridge NL, O'Connor CM, Pfeffer MA, Mehra MR, Solomon SD, Yancy CW, Fiuzat M, Mentz RJ, Collins SP, McMurray JJ, Vaduganathan M, Dunnmon PM, Rosano GM, Dinh W, Misselwitz F, Bonow RO, Gheorghiade M
Site selection for heart failure clinical trials in the USA. Heart Fail Rev. 2015 Jul; 20(4):375-83.
Site selection for heart failure clinical trials in the USA.
Foreword. The Winning Team in Heart Failure: Dimensionality of Care Redesign. Heart Fail Clin. 2015 Jul; 11(3):ix-x.
Foreword. The Winning Team in Heart Failure: Dimensionality of Care Redesign.
MY APPROACH to left ventricular assist device therapy. Trends Cardiovasc Med. 2015 Oct; 25(7):657-8.
MY APPROACH to left ventricular assist device therapy.
Mancini GB, Howlett JG, Borer J, Liu PP, Mehra MR, Pfeffer M, Swedberg K, Tardif JC
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms. Can J Cardiol. 2015 Oct; 31(10):1282-92.
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms.
Heart Failure: A Global Pandemic and Not Just a Disease of the West. Heart Fail Clin. 2015 Oct; 11(4):xiii-xiv.
Heart Failure: A Global Pandemic and Not Just a Disease of the West.
Stehlik J, Mehra MR, Sweet SC, Kirklin JK, Cypel M, Kirk R, Dipchand AI, Van Raemdonck D, Edwards LB, Mario Bertolotti A, Mejia JC, Torres Navas A, Potena L, Akar R, West LJ, Zuckermann A, Khaliel F, Davis DR, Reichenspurner H
The International Society for Heart and Lung Transplantation Registries in the Era of Big Data With Global Reach. J Heart Lung Transplant. 2015 Oct; 34(10):1225-32.
The International Society for Heart and Lung Transplantation Registries in the Era of Big Data With Global Reach.
Joyce E, Stewart GC, Hickey M, Coakley L, Rivero JM, Gosev I, Givertz MM, Couper GS, Mehra MR
Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis. J Heart Lung Transplant. 2015 Dec; 34(12):1561-9.
Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis.
Evolution in Mechanical Circulatory Support: Are We at the Precipice of a Disruptive Innovation? J Am Coll Cardiol. 2015 Dec 15; 66(23):2590-2593.
Evolution in Mechanical Circulatory Support: Are We at the Precipice of a Disruptive Innovation?
Pump thrombosis redux. J Heart Lung Transplant. 2015 Dec; 34(12):1511-4.
Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HJ, Taylor DO, Verschuuren EAM, Zuckermann A
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant. 2016 Jan; 35(1):1-23.
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.
Heatley G, Sood P, Goldstein D, Uriel N, Cleveland J, Middlebrook D, Mehra MR
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. J Heart Lung Transplant. 2016 Apr; 35(4):528-36.
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.
Clinical myocardial recovery during long-term mechanical support in advanced heart failure: Insights into moving the field forward. J Heart Lung Transplant. 2016 Apr; 35(4):413-20.
Clinical myocardial recovery during long-term mechanical support in advanced heart failure: Insights into moving the field forward.
Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes. Indian Heart J. 2016 Apr; 68 Suppl 1:S45-51.
Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes.
Netuka I, Kvasnicka T, Kvasnicka J, Hrachovinová I, Ivák P, Marecek F, Bílková J, Malíková I, Jancová M, Malý J, Sood P, Sundareswaran KS, Connors JM, Mehra MR
Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant. 2016 07; 35(7):860-7.
Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.
Body Composition and Advanced Heart Failure Therapy: Weighing the Options and Outcomes. JACC Heart Fail. 2016 10; 4(10):769-771.
Body Composition and Advanced Heart Failure Therapy: Weighing the Options and Outcomes.
Buckley LF, Seoane-Vazquez E, Cheng JW, Aldemerdash A, Cooper IM, Matta L, Medina DS, Mehra MR, Navarro-Velez K, Shea EL, Weintraub JR, Stevenson LW, Desai AS
Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure. Am J Cardiol. 2016 Nov 01; 118(9):1350-1355.
Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure.
Stehlik J, Bavaria JE, Bax J, Cronenwett JL, Edwards LB, Fairman RM, Ferrari R, Jacobs JP, Johnson MR, Kraiss LW, Masoudi FA, Mehra MR, Vahanian A, Walsh MN, Lund LH
Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation. J Heart Lung Transplant. 2016 10; 35(10):1149-1157.
Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation.
Guidelines for Listing Candidates for Heart Transplant: A 10-Year Update. JAMA Cardiol. 2017 01 01; 2(1):98-99.
Guidelines for Listing Candidates for Heart Transplant: A 10-Year Update.
Highlights of the Annual Scientific Meeting of the Heart Failure Society of America 2016. Circulation. 2016 11 08; 134(19):1505-1506.
Highlights of the Annual Scientific Meeting of the Heart Failure Society of America 2016.
Vulnerable Brain and Ventricular Assist Devices. Stroke. 2016 11; 47(11):2677-2678.
Vulnerable Brain and Ventricular Assist Devices.
Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC, Colombo PC, Walsh MN, Milano CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.
Sivathasan C, Lim CP, Kerk KL, Sim DK, Mehra MR
Mechanical circulatory support and heart transplantation in the Asia Pacific region. J Heart Lung Transplant. 2017 01; 36(1):13-18.
Mechanical circulatory support and heart transplantation in the Asia Pacific region.
Solo K, Mehra M, Dhawan R, Valant J, Scher HI
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Prevalence of prostate cancer (PC) clinical states (CS) in the United States: Estimates using a dynamic progression model. J Clin Oncol. 2011 May 20; 29(15_suppl):4637.
Prevalence of prostate cancer (PC) clinical states (CS) in the United States: Estimates using a dynamic progression model.
Late-onset right heart failure after left ventricular assist device implant: quo vadis? J Heart Lung Transplant. 2017 01; 36(1):26-27.
Late-onset right heart failure after left ventricular assist device implant: quo vadis?
Implementation Science and Global Connectivity: HFSA's Path Forward. J Card Fail. 2016 11; 22(11):937-938.
Implementation Science and Global Connectivity: HFSA's Path Forward.
Medical Director, BWH Heart and Vascular Center
An ACE in the hole: Unraveling gastrointestinal bleeding in left ventricular assist systemsAn ACE In The Hole: Unraveling Gastrointestinal Bleeding in Left Ventricular Assist Systemsretain-->. J Heart Lung Transplant. 2017 04; 36(4):373-375.
An ACE in the hole: Unraveling gastrointestinal bleeding in left ventricular assist systemsAn ACE In The Hole: Unraveling Gastrointestinal Bleeding in Left Ventricular Assist Systemsretain-->.
Gulati N, Kumar A, Lal P, Mehra M, Sahgal K
Preventing gastro-enteritis deaths: recommendations based on a 3 years study. J Commun Dis. 1995 Dec; 27(4):256-61.
Preventing gastro-enteritis deaths: recommendations based on a 3 years study.
Mehra MR, Stapleton DD, Cook JL, Zhang T, Ventura HO, Huang C, Maldonado B, Smart FW, Re RN, Murgo JP, Barbee RW
Adenovirus-mediated in vivo gene transfer in a rabbit model of allograft vasculopathy. J Heart Lung Transplant. 1996 Jan; 15(1 Pt 1):51-7.
Adenovirus-mediated in vivo gene transfer in a rabbit model of allograft vasculopathy.
Catheterization and cardiovascular diagnosis
Ventricular standstill complicating left heart catheterization in the presence of uncomplicated right bundle branch block. Cathet Cardiovasc Diagn. 1992 Nov; 27(3):212-4.
Ventricular standstill complicating left heart catheterization in the presence of uncomplicated right bundle branch block.
Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV
The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000 Dec; 36(7):2126-31.
The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure.
Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant. 2006 Jun; 6(6):1248-56.
Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy.
Mehra MR, Ventura HO, Jain SP, Ramireddy K, Ali A, Stapleton DD, Smart FW, Ramee SR, Collins TJ, White CJ
Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy. J Am Coll Cardiol. 1997 May; 29(6):1339-44.
Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.
Ancient Egyptian medicine and the concept of heart failure. J Card Fail. 2006 Aug; 12(6):416-21.
Ancient Egyptian medicine and the concept of heart failure.
Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH
Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail. 1999 Mar; 5(1):31-7.
Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock.
Radiocontrast-induced nephropathy. Prevention is better than cure. Postgrad Med. 1992 Dec; 92(8):215-8, 222-3.
Radiocontrast-induced nephropathy. Prevention is better than cure.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Treatment of pulmonary hypertension: a promising new age. Catheter Cardiovasc Interv. 2002 Nov; 57(3):395-403.
Treatment of pulmonary hypertension: a promising new age.
Heterosexual behaviour and condom usage in an urban population of Delhi, India. AIDS Care. 1997 Jun; 9(3):311-8.
Heterosexual behaviour and condom usage in an urban population of Delhi, India.
Gass A, Eisen H, Griffith B, Kobashigawa J, Koerner M, Mancini D, Mehra M, Meiser B, Webber S, Young J, Gilb E, Tuteja S
Current practices: immunosuppression induction, maintenance and rejection regimens in 213 consecutive transplant recipients. J Heart Lung Transplant. 2001 Feb; 20(2):162.
Current practices: immunosuppression induction, maintenance and rejection regimens in 213 consecutive transplant recipients.
Uber PA, Mehra MR, Vivekananthan N, Scott RL, Park MH
The differential metabolic impact of tacrolimus and cyclosporine immunosuppression in black heart transplant recipients: hyperlipidemia, hypertension and hyperglycemia. J Heart Lung Transplant. 2001 Feb; 20(2):192.
The differential metabolic impact of tacrolimus and cyclosporine immunosuppression in black heart transplant recipients: hyperlipidemia, hypertension and hyperglycemia.
Bordelon A, Uber PA, Dumas-Hicks D, Park MH, Scott RL, Mehra MR
Optimizing heart transplant patient education: is once enough? J Heart Lung Transplant. 2001 Feb; 20(2):243-244.
Optimizing heart transplant patient education: is once enough?
Difficult cases in heart failure: A hunt for reversibility: necessary and fruitful endeavor. Congest Heart Fail. 2000 Jul-Aug; 6(4):221-222.
Difficult cases in heart failure: A hunt for reversibility: necessary and fruitful endeavor.
Mehra MR, Uber PA, Park MH, Scott RL, Milani RV
Does HDL-cholesterol level predict clinical outcome in advanced heart failure? J Heart Lung Transplant. 2001 Feb; 20(2):165.
Does HDL-cholesterol level predict clinical outcome in advanced heart failure?
Costanzo MR, Eisen HJ, Brown RN, Mehra M, Benza R, Torre G, Yancy CW, Davis S, Mccloud M, Kirklin J
Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant. 2001 Feb; 20(2):152.
Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients.
Uber PA, Mehra MR, Park MH, Ventura H, Scott RL
Does hyperuricemia predict adverse clinical outcome while awaiting heart transplantation? J Heart Lung Transplant. 2001 Feb; 20(2):164-165.
Does hyperuricemia predict adverse clinical outcome while awaiting heart transplantation?
Potluri S, Prasad A, Uber PA, Scott RL, Park MH, Mehra MR
Ventricular asynchrony after heart transplantation: prevalence and clinical correlates. J Heart Lung Transplant. 2001 Feb; 20(2):237.
Ventricular asynchrony after heart transplantation: prevalence and clinical correlates.
Scott RL, Samal A, Hamdan T, Park MH, Howard R, Mehra MR
Are beta blockers effective in African Americans with systolic heart failure? J Heart Lung Transplant. 2001 Feb; 20(2):251.
Are beta blockers effective in African Americans with systolic heart failure?
Emergence of electronic home monitoring in chronic heart failure: rationale, feasibility, and early results with the HomMed Sentry-Observer system. Congest Heart Fail. 2000 May-Jun; 6(3):137-139.
Emergence of electronic home monitoring in chronic heart failure: rationale, feasibility, and early results with the HomMed Sentry-Observer system.
Kates MA, Meza MF, Mehra MR, Ventura HO, Revall S, D'Sa A, Murgo JP, Cheirif J
On-Line Myocardial Tissue Characterization with a New Commercially Produced Software. Echocardiography. 1996 May; 13(3):271-280.
On-Line Myocardial Tissue Characterization with a New Commercially Produced Software.
Grant A, Uber PA, Park MH, Scott RL, Mehra MR
Difficult cases in heart failure. Novel diagnostic markers in heart failure: an emerging paradigm shift? Congest Heart Fail. 2001 Sep-Oct; 7(5):274-276.
Difficult cases in heart failure. Novel diagnostic markers in heart failure: an emerging paradigm shift?
Higginbotham MB, Russell SD, Mehra MR, Ventura HO
Bridging patients to cardiac transplantation. Congest Heart Fail. 2000 Sep-Oct; 6(5):238-242.
Bridging patients to cardiac transplantation.
Pulsed inotropic therapy: an evangelical haven or justified sanctuary. Congest Heart Fail. 1999 Mar-Apr; 5(2):59-62.
Pulsed inotropic therapy: an evangelical haven or justified sanctuary.
Difficult cases in heart failure: Expanding the therapeutic armamentarium in decompensated heart failure: using intravenous fenoldopam. Congest Heart Fail. 2001 Jan-Feb; 7(1):51-52.
Difficult cases in heart failure: Expanding the therapeutic armamentarium in decompensated heart failure: using intravenous fenoldopam.
Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli F, Pagani M
Study of arterial and autonomic effects of cyclosporine in humans. Hypertension. 2000 Jun; 35(6):1258-63.
Study of arterial and autonomic effects of cyclosporine in humans.
Mehra MR, Uber PA, Walther D, Vesely M, Wohlgemuth JG, Prentice J, Tayama D, Billingham M
Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker. Circulation. 2006 Jul 04; 114(1 Suppl):I21-6.
Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker.
Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC
Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant. 2006 Dec; 25(12):1389-95.
Molecular testing in the management of cardiac transplant recipients: initial clinical experience.
Richards DR, Mehra MR, Ventura HO, Lavie CJ, Smart FW, Stapleton DD, Milani RV
Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men. Am J Cardiol. 1997 Nov 01; 80(9):1236-8.
Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men.
Robert James Graves and the cardiovascular responses to postural changes in heart failure. Am J Cardiol. 2000 Jun 15; 85(12):1503-6; A8.
Robert James Graves and the cardiovascular responses to postural changes in heart failure.
Greenberg B, Czerska B, Delgado RM, Bourge R, Zile MR, Silver M, Klapholz M, Haeusslein E, Mehra MR, Mather P, Abraham WT, Neaton JD, Brown BS, Parker IC, Konstam MA
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). Circulation. 2008 Sep 16; 118(12):1241-9.
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
Khanna AK, Xu J, Uber PA, Burke AP, Baquet C, Mehra MR
Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss. Circulation. 2009 Nov 03; 120(18):1814-21.
Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.
Park MH, Ramani GV, Kop WJ, Uber PA, Mehra MR
Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits. J Heart Lung Transplant. 2010 Feb; 29(2):228-9.
Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits.
Reed R, Mehra M, Kirshblum S, Maier D, Lammertse D, Blight A, Rupp R, Jones L, Abel R, Weidner N, Curt A, Steeves J
Spinal cord ability ruler: an interval scale to measure volitional performance after spinal cord injury. Spinal Cord. 2017 Aug; 55(8):730-738.
Spinal cord ability ruler: an interval scale to measure volitional performance after spinal cord injury.
The burden of haemocompatibility with left ventricular assist systems: a complex weave. Eur Heart J. 2019 02 21; 40(8):673-677.
The burden of haemocompatibility with left ventricular assist systems: a complex weave.
Mehra MR, Uber PA, Scott RL, Prasad AK, Park MH
Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1613-4.
Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation.
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation. 2002 Dec 15; 74(11):1568-73.
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.
Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003 Apr 01; 91(7):891-4.
Body composition and prognosis in chronic systolic heart failure: the obesity paradox.
White coat hypertension and sleep apnea: is there a link? Chest. 2004 Mar; 125(3):805-7.
White coat hypertension and sleep apnea: is there a link?
Evans RW, Williams GE, Baron HM, Deng MC, Eisen HJ, Hunt SA, Khan MM, Kobashigawa JA, Marton EN, Mehra MR, Mital SR
The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant. 2005 Jun; 5(6):1553-8.
The economic implications of noninvasive molecular testing for cardiac allograft rejection.
It is time to stop ignoring malignancy in heart transplantation: a call to arms. J Heart Lung Transplant. 2005 Aug; 24(8):1111-3.
It is time to stop ignoring malignancy in heart transplantation: a call to arms.
Khokhar A, Singh S, Talwar R, Rasania SK, Badhan SR, Mehra M
A study of malnutrition among children aged 6 months to 2 years from a resettlement colony of Delhi. Indian J Med Sci. 2003 Jul; 57(7):286-9.
A study of malnutrition among children aged 6 months to 2 years from a resettlement colony of Delhi.
Uriel N, Colombo PC, Cleveland JC, Long JW, Salerno C, Goldstein DJ, Patel CB, Ewald GA, Tatooles AJ, Silvestry SC, John R, Caldeira C, Jeevanandam V, Boyle AJ, Sundareswaran KS, Sood P, Mehra MR
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, Frohlich ED
Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004 May 05; 43(9):1590-5.
Obesity and suppressed B-type natriuretic peptide levels in heart failure.
Metaanalysis of statins and survival in de novo cardiac transplantation. Transplant Proc. 2004 Jun; 36(5):1539-41.
Metaanalysis of statins and survival in de novo cardiac transplantation.
Milani RV, Mehra MR, Lavie CJ, Ventura HO
Comparison of cardiac and peripheral arterial stiffening and ventriculovascular uncoupling in patients with uncomplicated hypertension versus patients with hypertension after heart transplantation. Am J Cardiol. 2006 Sep 15; 98(6):789-92.
Comparison of cardiac and peripheral arterial stiffening and ventriculovascular uncoupling in patients with uncomplicated hypertension versus patients with hypertension after heart transplantation.
Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M
Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant. 2006 Sep; 25(9):1024-42.
Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006 Sep 25; 166(17):1805-13.
Amyloidosis and the heart: a comprehensive review.
Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD
The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. J Heart Lung Transplant. 1997 Jul; 16(7):743-51.
The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Park MH, Scott RL, Uber PA, Harris BC, Chambers R, Mehra MR
Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol. 2002 Dec 15; 90(12):1326-9.
Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function.
Desperate diseases, desperate measures: tackling malignant hypertension in the 1950s. Am Heart J. 2001 Aug; 142(2):197-203.
Desperate diseases, desperate measures: tackling malignant hypertension in the 1950s.
Bedside b-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant. 2002 May; 21(5):613-4.
Bedside b-type natriuretic peptide and acute non-cellular cardiac allograft rejection.
Milani RV, Mehra MR, Endres S, Eigler A, Cooper ES, Lavie CJ, Ventura HO
The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest. 1996 Oct; 110(4):992-5.
The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia.
Houston BA, Shah KB, Mehra MR, Tedford RJ
A new "twist" on right heart failure with left ventricular assist systems. J Heart Lung Transplant. 2017 Jul; 36(7):701-707.
A new "twist" on right heart failure with left ventricular assist systems.
Milani RV, Mehra MR, Reddy TK, Lavie CJ, Ventura HO
Ventilation/carbon dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure. Heart. 1996 Nov; 76(5):393-6.
Ventilation/carbon dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure.
Bhatia DS, Bowen JC, Money SR, Van Meter CH, McFadden PM, Kot JB, Pridjian AK, Ventura HO, Mehra MR, Smart FW, Ochsner JL
The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation. Ann Surg. 1997 Jun; 225(6):686-93; discussion 693-4.
The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation.
Mehra MR, Cassidy CA, deGruiter HG, Ventura HO
The unique management of refractory advanced systolic heart failure. Heart Lung. 1997 Jul-Aug; 26(4):280-8.
The unique management of refractory advanced systolic heart failure.
Mehra MR, Uber PA, Scott RL, Park MH, Milani RV
Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume. Transplant Proc. 2002 Aug; 34(5):1866-8.
Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume.
The conundrum of sleep breathing disorders in heart failure. Chest. 2003 May; 123(5):1332-4.
The conundrum of sleep breathing disorders in heart failure.
Hippocrates and prognosis in heart failure: the challenge of static and dynamic measurements. Am Heart J. 2003 Aug; 146(2):215-7.
Hippocrates and prognosis in heart failure: the challenge of static and dynamic measurements.
Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol. 2004 Mar 17; 43(6):1056-61.
Reduction in C-reactive protein through cardiac rehabilitation and exercise training.
Brain injury and ventricular dysfunction: insights into reversible heart failure. Congest Heart Fail. 2005 Mar-Apr; 11(2):99-101.
Brain injury and ventricular dysfunction: insights into reversible heart failure.
Ali A, Mehra MR, Lavie CJ, Malik FS, Murgo JP, Lohmann TP, Li S, Lin HC, Milani RV
Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels. Am J Cardiol. 1998 Dec 15; 82(12):1543-5, A8.
Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels.
A specialist-nurse intervention reduced readmissions in patients hospitalized with chronic heart failure. ACP J Club. 2002 May-Jun; 136(3):87.
A specialist-nurse intervention reduced readmissions in patients hospitalized with chronic heart failure.
Uber PA, Mehra MR, Harris B, Scott RL, Park MH
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. Transplant Proc. 2002 Aug; 34(5):1843-4.
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation.
From crisis intervention to preventive intervention. A new approach to the management of heart failure. Tex Heart Inst J. 1998; 25(4):251-4.
From crisis intervention to preventive intervention. A new approach to the management of heart failure.
Crossing the vasculopathy bridge from morphology to therapy: a single center experience. J Heart Lung Transplant. 2000 Jun; 19(6):522-8.
Crossing the vasculopathy bridge from morphology to therapy: a single center experience.
Treatment of heart failure according to William Stokes: the enchanted mercury. J Card Fail. 2001 Sep; 7(3):277-82.
Treatment of heart failure according to William Stokes: the enchanted mercury.
Mehra M, Bahar RJ, Ament ME, Waldhausen J, Gershman G, Georgeson K, Fox V, Fishman S, Werlin S, Sato T, Hill I, Tolia V, Atkinson J
Journal of pediatric gastroenterology and nutrition
Laparoscopic and thoracoscopic esophagomyotomy for children with achalasia. J Pediatr Gastroenterol Nutr. 2001 Oct; 33(4):466-71.
Laparoscopic and thoracoscopic esophagomyotomy for children with achalasia.
Mehra MR, Uber PA, Potluri S, Ventura HO
Is heart failure with preserved systolic function an overlooked enigma? Curr Cardiol Rep. 2002 May; 4(3):187-93.
Is heart failure with preserved systolic function an overlooked enigma?
Vivekananthan K, Mehra MR, Uber PA, DeGruiter H, Lavie CJ, Milani RV
The Journal of the Association of Physicians of India
Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation. J Assoc Physicians India. 2002 May; 50(5):682-4.
Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.
Mehra MR, Ventura HO, Uber PA, Scott RL, Park MH
Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox. J Heart Lung Transplant. 2003 Feb; 22(2):118-23.
Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox.
Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J. 2005 Jan; 26(1):5-7.
Obesity and heart failure prognosis: paradox or reverse epidemiology?
Wu AH, Ballantyne CM, Short BC, Torre-Amione G, Young JB, Ventura HO, Eisen HJ, Radovancevic B, Rayburn BK, Lake KD, Yancy CW, Taylor DO, Mehra MR, Kubo SH, Fishbein DP, Zhao XQ, O'Brien KD
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. Am J Cardiol. 2005 Feb 01; 95(3):367-72.
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
Kobashigawa JA, Tobis JM, Starling RC, Tuzcu EM, Smith AL, Valantine HA, Yeung AC, Mehra MR, Anzai H, Oeser BT, Abeywickrama KH, Murphy J, Cretin N
Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005 May 03; 45(9):1532-7.
Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years.
Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. Circulation. 2005 Jun 21; 111(24):3327-35.
Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.
Marboe CC, Billingham M, Eisen H, Deng MC, Baron H, Mehra M, Hunt S, Wohlgemuth J, Mahmood I, Prentice J, Berry G
Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant. 2005 Jul; 24(7 Suppl):S219-26.
Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients.
Alaeddini J, Uber P, Park MH, Scott RL, Mehra MR
Sildenafil and assessment of pulmonary arterial reactivity in heart failure. Congest Heart Fail. 2003 May-Jun; 9(3):176-8.
Sildenafil and assessment of pulmonary arterial reactivity in heart failure.
Mehra MR, Uber PA, Uber WE, Scott RL, Park MH
Allosensitization in heart transplantation: implications and management strategies. Curr Opin Cardiol. 2003 Mar; 18(2):153-8.
Allosensitization in heart transplantation: implications and management strategies.
Left Ventricular Assist Devices for Advanced Heart Failure. N Engl J Med. 2017 05 11; 376(19):1894-5.
Left Ventricular Assist Devices for Advanced Heart Failure.
Calcineurin-inhibitor withdrawal in heart transplantation recipients (the case against). Transplant Proc. 2002 Aug; 34(5):1825-7.
Calcineurin-inhibitor withdrawal in heart transplantation recipients (the case against).
Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, Liu PP, Konstam MA, Greenberg B, Mehra MR, Breithardt G, Pang PS, Young JB, Fonarow GC, Bonow RO, Gheorghiade M
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009 Jan 20; 53(3):254-63.
Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment.
Mehra MR, Uber PA, Prasad AK, Park MH, Scott RL, McFadden PM, Van Meter CH
Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses. J Heart Lung Transplant. 2000 Aug; 19(8):801-4.
Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses.
Adverse effects of nicotine and immunosuppression on proximal tubular epithelial cell viability, tissue repair and oxidative stress gene expression. J Heart Lung Transplant. 2009 Jun; 28(6):612-20.
Adverse effects of nicotine and immunosuppression on proximal tubular epithelial cell viability, tissue repair and oxidative stress gene expression.
Gheorghiade M, Thyssen A, Zolynas R, Nadar VK, Greenberg BH, Mehra M, Sun X, Tian H, Plotnikov AN, Burton P
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure. J Heart Lung Transplant. 2011 Feb; 30(2):218-26.
Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure.
Berry GJ, Angelini A, Burke MM, Bruneval P, Fishbein MC, Hammond E, Miller D, Neil D, Revelo MP, Rodriguez ER, Stewart S, Tan CD, Winters GL, Kobashigawa J, Mehra MR
The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant. 2011 Jun; 30(6):601-11.
The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011).
Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation. 2004 Jul 27; 110(4):e27-31.
Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea?
Life style and morbidity profile of geriatric population in an urbans community of Delhi. Indian J Med Sci. 2001 Nov; 55(11):609-15.
Life style and morbidity profile of geriatric population in an urbans community of Delhi.
Alaeddini J, Uber PA, Park MH, Scott RL, Ventura HO, Mehra MR
Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol. 2004 Dec 01; 94(11):1475-7.
Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure.
Morshedi-Meibodi A, Menuet R, McFadden M, Ventura HO, Mehra MR
Is it constrictive pericarditis or restrictive cardiomyopathy? A systematic approach. Congest Heart Fail. 2004 Nov-Dec; 10(6):309-12.
Is it constrictive pericarditis or restrictive cardiomyopathy? A systematic approach.
Mehra MR, Zucker MJ, Wagoner L, Michler R, Boehmer J, Kovarik J, Vasquez A
A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. J Heart Lung Transplant. 2005 Sep; 24(9):1297-304.
A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation.
Woods DM, Johnson J, Holl JL, Mehra M, Thomas EJ, Ogata ES, Lannon C
Anatomy of a patient safety event: a pediatric patient safety taxonomy. Qual Saf Health Care. 2005 Dec; 14(6):422-7.
Anatomy of a patient safety event: a pediatric patient safety taxonomy.
Kobashigawa JA, Tobis JM, Mentzer RM, Valantine HA, Bourge RC, Mehra MR, Smart FW, Miller LW, Tanaka K, Li H, Gjertson DW, Gordon RD
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am J Transplant. 2006 May; 6(5 Pt 1):993-7.
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial.
Greenberg BH, Mehra M, Teerlink JR, Ordronneau P, McCollum D, Gilbert EM
COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure. Am J Cardiol. 2006 Oct 02; 98(7A):53L-59L.
COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.
Ventura HO, Mehra MR, Stapleton DD, Smart FW
Cyclosporine-induced hypertension in cardiac transplantation. Med Clin North Am. 1997 Nov; 81(6):1347-57.
Cyclosporine-induced hypertension in cardiac transplantation.
Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc. 2006 Dec; 81(12):1603-11.
Understanding the basics of cardiopulmonary exercise testing.
Sperber K, Shim J, Mehra M, Lin A, George I, Ogata S, Mayer L, Itzkowitz S
Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues. Inflamm Bowel Dis. 1998 Feb; 4(1):12-7.
Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues.
Pinney SP, Anyanwu AC, Lala A, Teuteberg JJ, Uriel N, Mehra MR
Left Ventricular Assist Devices for Lifelong Support. J Am Coll Cardiol. 2017 Jun 13; 69(23):2845-2861.
Left Ventricular Assist Devices for Lifelong Support.
Krishnan P, Ventura HO, Uber PA, Arcement LM, Mehra MR
Treatment of hypertension for patients with diastolic dysfunction. Curr Opin Cardiol. 2003 Jul; 18(4):272-7.
Treatment of hypertension for patients with diastolic dysfunction.
B-type natriuretic peptide in heart transplantation: an important marker of allograft performance. Heart Fail Rev. 2003 Oct; 8(4):359-63.
B-type natriuretic peptide in heart transplantation: an important marker of allograft performance.
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
The historical odyssey of cardiac transplantation. J La State Med Soc. 2003 Nov-Dec; 155(6):344-7.
The historical odyssey of cardiac transplantation.
Mehra MR, Benza R, Deng MC, Russell S, Webber S
Surrogate markers for late cardiac allograft survival. Am J Transplant. 2004 Jul; 4(7):1184-91.
Surrogate markers for late cardiac allograft survival.
Mehra MR, Jessup M, Gronda E, Costanzo MR
Rationale and process: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant. 2006 Sep; 25(9):1001-2.
Rationale and process: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy. Circulation. 2006 Dec 12; 114(24):2685-90; discussion 2691.
All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy.
Shah KB, Nolan MM, Rao K, Wang DJ, Christenson RH, Shanholtz CB, Mehra MR, Gottlieb SS
The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am J Med. 2007 Dec; 120(12):1071-7.
The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients.
Imaging markers of adverse remodeling: from organ to organelle. Heart Fail Clin. 2006 Apr; 2(2):117-27.
Imaging markers of adverse remodeling: from organ to organelle.
Mehra MR, Kobashigawa JA, Deng MC, Fang KC, Klingler TM, Lal PG, Rosenberg S, Uber PA, Starling RC, Murali S, Pauly DF, Dedrick R, Walker MG, Zeevi A, Eisen HJ
Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection. J Heart Lung Transplant. 2008 Mar; 27(3):297-301.
Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection.
Advances in heart and lung transplantation 2004: Report from the 24th International Society for Heart and Lung Transplantation Annual Meeting, San Francisco, April 21-24, 2004. J Heart Lung Transplant. 2004 Aug; 23(8):925-30.
Advances in heart and lung transplantation 2004: Report from the 24th International Society for Heart and Lung Transplantation Annual Meeting, San Francisco, April 21-24, 2004.
Difficult cases in heart failure: amiodarone lung injury: another heart failure mimic? Congest Heart Fail. 2002 Mar-Apr; 8(2):93-6.
Difficult cases in heart failure: amiodarone lung injury: another heart failure mimic?
Lavie CJ, Milani R, Mehra MR, Ventura HO, Messerli FH
Obesity, weight reduction and survival in heart failure. J Am Coll Cardiol. 2002 May 01; 39(9):1563; author reply 1563-4.
Obesity, weight reduction and survival in heart failure.
Cardiomyopathy and the dilemma of geometric mitral regurgitation. Curr Opin Cardiol. 2009 Mar; 24(2):179-83.
Cardiomyopathy and the dilemma of geometric mitral regurgitation.
The 500 heart transplant. Ochsner J. 2000 Apr; 2(2):120-1.
File E, Mehra M, Nair S, Dumas-Hicks D, Perrillo R
Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation. Transplantation. 2003 Oct 15; 76(7):1096-100.
Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation.
Mehra MR, Stapleton DD, Ventura HO, Escobar A, Cassidy CA, Smart FW, Collins TJ, Ramee SR, White CJ
Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study. Circulation. 1994 Nov; 90(5 Pt 2):II78-82.
Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR, Uber PA, Prasad A, Scott RL, Park MH
Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers. Am J Transplant. 2005 May; 5(5):1137-40.
Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers.
Lavie CJ, Milani RV, Mehra MR, Ventura HO
Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009 Aug 11; 54(7):585-94.
Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie CJ, O'Keefe JH, Milani RV, Ventura HO, Mehra MR
New data on the clinical impact of exercise training, fish oils, and statins in heart failure. Phys Sportsmed. 2009 Jun; 37(2):22-8.
New data on the clinical impact of exercise training, fish oils, and statins in heart failure.
Predicting prognosis in advanced heart failure. Use of exercise indices. Chest. 1996 Aug; 110(2):310-2.
Predicting prognosis in advanced heart failure. Use of exercise indices.
Methodological challenges of genomic research--the CARGO study. Am J Transplant. 2006 May; 6(5 Pt 1):1086-7.
Methodological challenges of genomic research--the CARGO study.
Malik FS, Mehra MR, Ventura HO, Smart FW, Stapleton DD, Ochsner JL
Management of cardiac allograft vasculopathy by transmyocardial laser revascularization. Am J Cardiol. 1997 Jul 15; 80(2):224-5.
Management of cardiac allograft vasculopathy by transmyocardial laser revascularization.
Tavora F, Munivenkatappa R, Papadimitriou J, Drachenberg C, Sailey C, Mehra M, Burke A
Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection. J Heart Lung Transplant. 2011 Apr; 30(4):435-44.
Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection.
Pulmonary hypertension: the great leveler. J Am Coll Cardiol. 2012 Jan 17; 59(3):232-4.
Pulmonary hypertension: the great leveler.
The dawn of the ISHLT Mechanical Assisted Circulatory Support (IMACS) Registry: fulfilling our mission. J Heart Lung Transplant. 2012 Feb; 31(2):115-6.
The dawn of the ISHLT Mechanical Assisted Circulatory Support (IMACS) Registry: fulfilling our mission.
Shah MR, Starling RC, Schwartz Longacre L, Mehra MR
Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group. J Am Coll Cardiol. 2012 Apr 03; 59(14):1263-9.
Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group.
Clinicians and nutraceutical use in cardiology patients: ignorance and neglect. Ann Intern Med. 2010 Jul 06; 153(1):65-6.
Clinicians and nutraceutical use in cardiology patients: ignorance and neglect.
Kim M, Bergmark BA, Zelniker TA, Mehra MR, Stewart GC, Page DS, Woodcome EL, Smallwood JA, Gabardi S, Givertz MM
Early aspirin use and the development of cardiac allograft vasculopathy. J Heart Lung Transplant. 2017 Dec; 36(12):1344-1349.
Early aspirin use and the development of cardiac allograft vasculopathy.
Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF. J Am Heart Assoc. 2012 Feb; 1(1):16-26.
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF.
Cleveland JC, Goldstein DJ, Uriel N, Mehra MR
Forward "MOMENTUM" in left ventricular assist systems: advanced engineering meets biology. J Thorac Dis. 2017 Jul; 9(7):E653-E655.
Forward "MOMENTUM" in left ventricular assist systems: advanced engineering meets biology.
Evolocumab in Patients with Cardiovascular Disease. N Engl J Med. 2017 08 24; 377(8):785-6.
Evolocumab in Patients with Cardiovascular Disease.
Zile MR, Colombo PC, Mehra M, Greenberg B, Brown S, Konstam MA
Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM). J Heart Lung Transplant. 2010 Jan; 29(1):86-92.
Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
Mehra MR, Ventura HO, Smart FW, Stapleton DD, Collins TJ, Ramee SR, Murgo JP, White CJ
New developments in the diagnosis and management of cardiac allograft vasculopathy. Tex Heart Inst J. 1995; 22(2):138-44.
New developments in the diagnosis and management of cardiac allograft vasculopathy.
Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group. Am J Med. 1994 Jun 06; 96(6A):87S-93S.
Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group.
Imamura T, Chung B, Nguyen A, Rodgers D, Sayer G, Adatya S, Sarswat N, Kim G, Raikhelkar J, Ota T, Song T, Juricek C, Kagan V, Jeevanandam V, Mehra M, Burkhoff D, Uriel N
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation. Circ Heart Fail. 2017 Sep; 10(9).
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
Vivekananthan K, Kalapura T, Mehra M, Lavie C, Milani R, Scott R, Park M
Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Cardiol. 2002 Sep 01; 90(5):517-20.
Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection.
Early recognition and treatment of hypertensive heart disease. Curr Opin Cardiol. 2005 Jul; 20(4):282-9.
Early recognition and treatment of hypertensive heart disease.
Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, Kobashigawa J, Johnson FL, Starling RC, Murali S, Pauly DF, Baron H, Wohlgemuth JG, Woodward RN, Klingler TM, Walther D, Lal PG, Rosenberg S, Hunt S
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006 Jan; 6(1):150-60.
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.
The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside. Nat Clin Pract Cardiovasc Med. 2006 Mar; 3(3):136-43.
The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside.
Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, Oconnor CM, Reynolds D, Walsh MN, Fonarow GC
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009 Dec; 158(6):956-64.
Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF.
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Am Heart J. 2010 Feb; 159(2):238-44.
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Am J Cardiol. 2010 Apr 15; 105(8):1140-6.
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
Impact of exercise training and depression on survival in heart failure due to coronary heart disease. Am J Cardiol. 2011 Jan; 107(1):64-8.
Impact of exercise training and depression on survival in heart failure due to coronary heart disease.
Kransdorf EP, Mehta HS, Shah KB, Vucicevic D, DePasquale EC, Goldraich L, Ciarka A, Masetti M, Youn JC, Irving C, Khaliel F, Schweiger M, Uber P, Mehra MR, Stehlik J
ISHLT Transplant Registry: Youthful Investment-The Path to Progress. J Heart Lung Transplant. 2017 10; 36(10):1027-1036.
ISHLT Transplant Registry: Youthful Investment-The Path to Progress.
Buise M, Van Bommel J, Mehra M, Tilanus HW, Van Zundert A, Gommers D
Pulmonary morbidity following esophagectomy is decreased after introduction of a multimodal anesthetic regimen. Acta Anaesthesiol Belg. 2008; 59(4):257-61.
Pulmonary morbidity following esophagectomy is decreased after introduction of a multimodal anesthetic regimen.
Vaduganathan M, DeFilippis EM, Fonarow GC, Butler J, Mehra MR
Postmarketing Adverse Events Related to the CardioMEMS HF System. JAMA Cardiol. 2017 11 01; 2(11):1277-1279.
Postmarketing Adverse Events Related to the CardioMEMS HF System.
Mehra MR, Ventura HO, Smart FW, Collins TJ, Ramee SR, Stapleton DD
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. Am J Cardiol. 1995 Apr 15; 75(12):853-4.
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Heart failure therapy at a crossroad: are there limits to the neurohormonal model? J Am Coll Cardiol. 2003 May 07; 41(9):1606-10.
Heart failure therapy at a crossroad: are there limits to the neurohormonal model?
Destination therapy in late-stage heart failure. Coron Artery Dis. 2004 Mar; 15(2):87-90.
Destination therapy in late-stage heart failure.
Improvement of heart failure after renal transplantation: the complex maze of cardio-renal interaction. J Am Coll Cardiol. 2005 Apr 05; 45(7):1061-3.
Improvement of heart failure after renal transplantation: the complex maze of cardio-renal interaction.
Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure. Clin Cornerstone. 2005; 7 Suppl 1:S7-17.
Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure.
The emergence of genomic and proteomic biomarkers in heart transplantation. J Heart Lung Transplant. 2005 Jul; 24(7 Suppl):S213-8.
The emergence of genomic and proteomic biomarkers in heart transplantation.
Kobashigawa JA, Starling RC, Mehra MR, Kormos RL, Bhat G, Barr ML, Sigouin CS, Kolesar J, Fitzsimmons W
Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant. 2006 Sep; 25(9):1063-9.
Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.
Induction therapy in heart transplantation: is there a role? J Heart Lung Transplant. 2007 Mar; 26(3):205-9.
Induction therapy in heart transplantation: is there a role?
Genomic biomarkers and heart transplantation. Heart Fail Clin. 2007 Jan; 3(1):83-6.
Genomic biomarkers and heart transplantation.
Mehra MR, Uber PA, Uber WE, Park MH, Scott RL
Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection. Curr Opin Cardiol. 2002 Mar; 17(2):131-6.
Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection.
The interaction of vascular stiffness and cardiovascular events in women: insights from The Heart and Estrogen/Progestin Replacement Study. Chest. 2005 May; 127(5):1477-80.
The interaction of vascular stiffness and cardiovascular events in women: insights from The Heart and Estrogen/Progestin Replacement Study.
Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006 Jun 06; 47(11):2245-52.
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure.
Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts. J Heart Lung Transplant. 2007 Dec; 26(12):1255-63.
Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts.
Isolated tricuspid stenosis and heart failure: a focus on carcinoid heart disease. Congest Heart Fail. 2003 Sep-Oct; 9(5):294-6.
Isolated tricuspid stenosis and heart failure: a focus on carcinoid heart disease.
Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol. 2004 Apr 07; 43(7):1145-8.
Cardiac resynchronization therapy: caveat medicus!
Response by Mehra et al to Letter Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure". Circulation. 2017 11 07; 136(19):1872-1873.
Response by Mehra et al to Letter Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure".
Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant. 2006 Jul; 25(7):834-8.
Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure.
Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, Mehra M, O'Connor CM, Reynolds D, Walsh MN
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007 Jul; 154(1):12-38.
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
Sexual activity and chronic heart failure. Mayo Clin Proc. 2007 Oct; 82(10):1203-10.
Sexual activity and chronic heart failure.
Lavie CJ, Milani RV, Ventura HO, Cardenas GA, Mehra MR, Messerli FH
Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol. 2007 Nov 01; 100(9):1460-4.
Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction.
The cardiac allograft is going up in smoke: a call to action. Am J Transplant. 2008 Apr; 8(4):737-8.
The cardiac allograft is going up in smoke: a call to action.
Mehra MR, Ventura HO, Stapleton DD, Smart FW, Collins TC, Ramee SR
Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant. 1995 Jul-Aug; 14(4):632-9.
Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.
Goldstein DJ, Mehra MR, Naka Y, Salerno C, Uriel N, Dean D, Itoh A, Pagani FD, Skipper ER, Bhat G, Raval N, Bruckner BA, Estep JD, Cogswell R, Milano C, Fendelander L, O'Connell JB, Cleveland J
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 01; 37(1):7-14.
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.
Ischemic stroke and subsequent thrombosis within a HeartMate 3 left ventricular assist system: A cautionary tale. J Heart Lung Transplant. 2018 01; 37(1):170-172.
Ischemic stroke and subsequent thrombosis within a HeartMate 3 left ventricular assist system: A cautionary tale.
The scourge and enigmatic journey of cardiac allograft vasculopathy. J Heart Lung Transplant. 2017 12; 36(12):1291-1293.
The scourge and enigmatic journey of cardiac allograft vasculopathy.
Challenges, diligence, and a breakthrough in donation after circulatory death in heart transplantation. J Heart Lung Transplant. 2017 12; 36(12):1319-1321.
Challenges, diligence, and a breakthrough in donation after circulatory death in heart transplantation.
Lavie CJ, Milani RV, Ventura HO, Mehra MR
Peak oxygen consumption and heart failure prognosis in women. J Am Coll Cardiol. 2007 Jan 23; 49(3):375; author reply 375-6.
Peak oxygen consumption and heart failure prognosis in women.
Greenberg BH, Anand IS, Burnett JC, Chin J, Dracup KA, Feldman AM, Force T, Francis GS, Houser SR, Hunt SA, Konstam MA, Lindenfeld J, Mann DL, Mehra MR, Paul SC, Piano MR, Ross HJ, Sabbah HN, Starling RC, Udelson JE, Yancy CW, Zile MR, Massie BM
The Heart Failure Society of America in 2020: a vision for the future. J Card Fail. 2012 Feb; 18(2):90-3.
The Heart Failure Society of America in 2020: a vision for the future.
Bravo PE, Bergmark BA, Vita T, Taqueti VR, Gupta A, Seidelmann S, Christensen TE, Osborne MT, Shah NR, Ghosh N, Hainer J, Bibbo CF, Harrington M, Costantino F, Mehra MR, Dorbala S, Blankstein R, Desai A, Stevenson L, Givertz MM, Di Carli MF
Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy.
Vesely MR, Li S, Kop WJ, Reese A, Marshall J, Shorofsky SR, Gottlieb SS, Mehra MR, Gottdiener JS
Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol. 2008 Mar 01; 101(5):645-50.
Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography.
Prevention of atherosclerosis. Postgrad Med. 1995 Jul; 98(1):175-184.
Heart transplantation at 50. Lancet. 2017 Dec 02; 390(10111):e43-e45.
Uber PA, Ross HJ, Zuckermann AO, Sweet SC, Corris PA, McNeil K, Mehra MR
Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory. J Heart Lung Transplant. 2009 Jul; 28(7):655-60.
Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.
Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008 Jul; 1(2):98-106.
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
Mehra MR, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, O'Connor CM, Reynolds D, Walsh MN, Fonarow GC
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009 Dec; 6(12):1727-34.
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.
Gene expression profiling and cardiac allograft rejection monitoring: is IMAGE just a mirage? J Heart Lung Transplant. 2010 Jun; 29(6):599-602.
Gene expression profiling and cardiac allograft rejection monitoring: is IMAGE just a mirage?
Adams KF, Mehra MR, Oren RM, O'Connor CM, Chiong JR, Ghali JK, Lenihan DJ, Dunlap SH, Patterson JH, Schwartz TA, Felker GM
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure. Am Heart J. 2010 Dec; 160(6):1142-8.
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure.
Madathil RJ, Gilstrap LG, Pelletier MP, Mehra MR
Isolated hyperammonemic encephalopathy in heart transplantation. J Heart Lung Transplant. 2018 03; 37(3):427-429.
Isolated hyperammonemic encephalopathy in heart transplantation.
Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S, Hanson K, Mehra MR, deFilippi CR
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Clin Chem. 2009 Jan; 55(1):59-67.
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
Beitelshees AL, Horenstein RB, Vesely MR, Mehra MR, Shuldiner AR
Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions. Clin Pharmacol Ther. 2011 Mar; 89(3):455-9.
Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.
Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW
Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011 Apr 19; 123(15):1601-10.
Associations between outpatient heart failure process-of-care measures and mortality.
Emergency cardiovascular care: from ED to CCU and beyond. Cardiol Clin. 2012 Nov; 30(4):xiii-xiv.
Emergency cardiovascular care: from ED to CCU and beyond.
Esch JJ, Shah PB, Cockrill BA, Farber HW, Landzberg MJ, Mehra MR, Mullen MP, Opotowsky AR, Waxman AB, Lock JE, Marshall AC
Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7.
Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience.
Adams KF, Piña IL, Ghali JK, Wagoner LE, Dunlap SH, Schwartz TA, Stough WG, Mehra MR, Felker GM, Chiong JR, Patterson JH, Kim J, Butler J, Oren RM
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure. Am Heart J. 2009 Dec; 158(6):965-71.
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure.
Pandhi J, Gottdiener JS, Bartz TM, Kop WJ, Mehra MR
Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study). Am J Cardiol. 2011 Jun 01; 107(11):1667-74.
Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study).
Blood pressure and goal titration of neurohormonal antagonists: the tortoise wins again? Eur J Heart Fail. 2018 03; 20(3):501-503.
Blood pressure and goal titration of neurohormonal antagonists: the tortoise wins again?
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol. 2013 Jan 15; 254(1-2):69-75.
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
Current treatment options in cardiovascular medicine
The progressive cardiorenal syndrome in heart failure: mechanisms and therapeutic insights. Curr Treat Options Cardiovasc Med. 2008 Aug; 10(4):342-8.
The progressive cardiorenal syndrome in heart failure: mechanisms and therapeutic insights.
Mehra MR, Ventura HO, Chambers R, Collins TJ, Ramee SR, Kates MA, Smart FW, Stapleton DD
Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 1995 Nov 15; 26(6):1537-44.
Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
Gheorghiade M, Albert NM, Curtis AB, Thomas Heywood J, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Congest Heart Fail. 2012 Jan-Feb; 18(1):9-17.
Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF.
Ventura HO, Malik FS, Mehra MR, Stapleton DD, Smart FW
Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol. 1997 Jul; 12(4):375-81.
Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine.
Harjai KJ, Mehra MR, Ventura HO, Lapeyre YM, Murgo JP, Stapleton DD, Smart FW
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes. Chest. 1997 Nov 05; 112(5):1298-303.
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
Jain SP, Ramee SR, White CJ, Mehra MR, Ventura HO, Zhang S, Jenkins JS, Collins TJ
Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol. 1998 Nov 15; 32(6):1636-40.
Coronary stenting in cardiac allograft vasculopathy.
Ali A, Mehra MR, Malik FS, Lavie CJ, Bass D, Milani RV
Effects of aerobic exercise training on indices of ventricular repolarization in patients with chronic heart failure. Chest. 1999 Jul; 116(1):83-7.
Effects of aerobic exercise training on indices of ventricular repolarization in patients with chronic heart failure.
Difficulties of the staff posted for intensive pulse polio immunization in Delhi. Indian J Med Sci. 2000 Nov; 54(11):481-4.
Difficulties of the staff posted for intensive pulse polio immunization in Delhi.
Toda K, Mackenzie K, Mehra MR, DiCorte CJ, Davis JE, McFadden PM, Ochsner JL, White C, Van Meter CH
Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%): a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg. 2002 Dec; 74(6):2082-7; discussion 2087.
Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%): a comparison of bypass grafting and percutaneous intervention.
TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit? J Heart Lung Transplant. 2003 May; 22(5):501-4.
TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?
Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC, Francis GS, Mehra MR, Peacock WF, Fonarow G, Gibler WB, Morrow DA, Hollander J
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004 Sep-Oct; 10(5 Suppl 3):1-30.
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.
Mehra MR, Milani RV, Richie MB, Uber PA, Park MH, Ventura HO, Scott RL, Lavie CJ
Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. Transplant Proc. 2004 Dec; 36(10):3149-51.
Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation.
Balancing the tightrope of cardiac allograft rejection: equations or experience? Circulation. 2012 Jun 19; 125(24):2971-4.
Balancing the tightrope of cardiac allograft rejection: equations or experience?
Reynolds D, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mcbride ML, Inge PJ, Mehra MR, O'Connor CM, Walsh MN, Yancy CW, Fonarow GC
Journal of the National Medical Association
Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. J Natl Med Assoc. 2012 May-Jun; 104(5-6):287-98.
Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF.
Mehra MR, Uber PA, Park MH, Prasad AK, Scott RL
A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. Transplant Proc. 2001 Feb-Mar; 33(1-2):1606-7.
A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients.
Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study). Am J Cardiol. 2002 Nov 15; 90(10):1133-4.
Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study).
Mehra MR, Uber PA, Vivekananthan K, Solis S, Scott RL, Park MH, Milani RV, Lavie CJ
Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol. 2002 Nov 06; 40(9):1609-14.
Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival.
Mehra MR, Ventura HO, Kapoor C, Stapleton DD, Zimmerman D, Smart FW
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Am J Cardiol. 1997 Jul 01; 80(1):61-4.
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli FH, Murgo JP, Regenstein F, Copley B, Malliani A, Pagani M
Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control. J Heart Lung Transplant. 1997 Jun; 16(6):615-20.
Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
Malik FS, Lavie CJ, Mehra MR, Milani RV, Re RN
Renin-angiotensin system: genes to bedside. Am Heart J. 1997 Sep; 134(3):514-26.
Renin-angiotensin system: genes to bedside.
Colles-Stokes contributions to the concept of heart failure. Am J Cardiol. 1998 Jun 15; 81(12):1470-3.
Colles-Stokes contributions to the concept of heart failure.